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Abstract
Mutations in the Aristaless-related homeobox (ARX) gene are found in a spectrum of epilepsy and Xlinked intellectual disability disorders in children. During development Arx is expressed in pallial
ventricular zone (VZ) progenitor cells which give rise to the excitatory projection neurons of the cortex.
Arx-/Y mice were shown to have decreased proliferation in the cortical VZ resulting in smaller brains;
however, the basis for this reduced proliferation was not established. To determine the role of ARX on cell
cycle dynamics in cortical progenitor cells, we generated cerebral cortex specific Arx mouse mutants
(cKO). The loss of pallial Arx resulted in the reduction of cortical progenitor cells, particularly affected was
the proliferation of intermediate progenitor cells (IPCs). The mechanism was determined to be due to an
overexpression of CDKN1C, an inhibitor of cell cycle progression, in the cortical VZ and SVZ of Arx KOs
throughout corticogenesis. We also identified CDKN1C through transcriptional profile analysis of Arx KO
cortices and showed that ARX is a direct regulator of Cdkn1c transcription. Later in development and
postnatally cKO corticies showed a reduction of upper layer but not deeper layer neurons consistent with
the IPC defect. The phenotype of the adult cKO mice is different from all other Arx mutant mice. They
have no discernable seizure activity and are less anxious, less social, and more active when compared to
their wild type littermates. Anatomically, there are significant changes with reduced cortical thickness and
a hypoplastic corpus callosum and anterior commissure both consistent with a perturbation in cortical
connectivity. Together, these data suggest specific structural and behavioral anomalies, common in
patients with ARX mutations, are specifically due to alterations in pallial progenitor function. Furthermore,
and of considerable interest, our data demonstrate that some of the neurobehavioral features found in
patients with ARX mutations are not due to on-going seizures, as is often postulated, as the confounding
variable of epilepsy was eliminated in these behavior analyses.
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ABSTRACT

ARX INFLUENCES CORTICAL FUNCTION BY REGULATING PROGENITOR CELL
PROLIFERATION
Jacqueline Simonet
Jeffrey Golden
Eric Marsh
Mutations in the Aristaless-related homeobox (ARX) gene are found in a spectrum of epilepsy and
X-linked intellectual disability disorders in children. During development Arx is expressed in
pallial ventricular zone (VZ) progenitor cells which give rise to the excitatory projection neurons
of the cortex. Arx-/Y mice were shown to have decreased proliferation in the cortical VZ resulting
in smaller brains; however, the basis for this reduced proliferation was not established. To
determine the role of ARX on cell cycle dynamics in cortical progenitor cells, we generated
cerebral cortex specific Arx mouse mutants (cKO). The loss of pallial Arx resulted in the
reduction of cortical progenitor cells, particularly affected was the proliferation of intermediate
progenitor cells (IPCs). The mechanism was determined to be due to an overexpression of
CDKN1C, an inhibitor of cell cycle progression, in the cortical VZ and SVZ of Arx KOs
throughout corticogenesis. We also identified CDKN1C through transcriptional profile analysis
of Arx KO cortices and showed that ARX is a direct regulator of Cdkn1c transcription. Later in
development and postnatally cKO corticies showed a reduction of upper layer but not deeper
layer neurons consistent with the IPC defect. The phenotype of the adult cKO mice is different
from all other Arx mutant mice. They have no discernable seizure activity and are less anxious,
less social, and more active when compared to their wild type littermates. Anatomically, there
are significant changes with reduced cortical thickness and a hypoplastic corpus callosum and
anterior commissure both consistent with a perturbation in cortical connectivity. Together, these
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data suggest specific structural and behavioral anomalies, common in patients with ARX
mutations, are specifically due to alterations in pallial progenitor function. Furthermore, and of
considerable interest, our data demonstrate that some of the neurobehavioral features found in
patients with ARX mutations are not due to on-going seizures, as is often postulated, as the
confounding variable of epilepsy was eliminated in these behavior analyses.
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CHAPTER 1: Introduction

Epilepsy, intellectual disability, and other neurological disorders are major causes
of childhood morbidity and mortality. The development of effective therapies relies, in
part, on determining the pathogenic mechanisms of these various disorders.
Complicating this process is the increasing recognition that identification of a specific
genetic mutation does not, a priori, immediately elucidate the neurobiologic defect
resulting in a particular disorder. In order to understand how known mutations in
particular genes affect brain development and function we first need to understand how
those genes function in normal brain development. My thesis work has focused on
beginning to answer these questions for one particular gene, Arx, in the cerebral cortex of
mice.
Development of the Cerebral Cortex
Understanding how changes in one gene affect cerebral cortical development
requires first appreciating normal cortical development. Early in development the
embryo consists of three cell layers, the inner most layer is the endoderm, the middle is
the mesoderm, and the outer most layer is the ectoderm. The ectoderm gives rise to the
central and peripheral nervous system along with the integumentary system. Shortly after
the development of these three embryonic layers a central sheet of cells are specified as a
neural plate at the dorsal midline of the embryo. The neural plate morphs into a neural
tube due to proliferation, invagination, and pinching off of ectodermal cells from the
surface (Alvarez IS and GC Schoenwolf 1992; Lawson A et al. 2001; Gilbert SF 2010).
After the most anterior part of the neural tube has closed it begins to form bulges or
1

vesicles. The most anterior bulge, the prosencephalon, eventually becomes the forebrain
of the embryo. As brain development proceeds this single vesicle divides in the anteriorposterior plane to become two vesicles, the telencephalon and the diencephalon. Over
time the most anterior vesicle, the telencephalon, expands significantly in the medial
lateral plan to become the large, bilaterally symmetric cerebral hemispheres. The cells in
these vesicles will ultimately give rise to the cerebral cortex, hippocampus, basal ganglia,
and olfactory bulbs. (For review see (Kandel ER et al. 2000; Gilbert SF 2010))
During these early developmental stages the telencephalon is made up of
primarily progenitor cells, which continually proliferate to generate more progenitor cells
(Gotz M and YA Barde 2005). The progenitor cells in the dorsal aspect of the
telencephalic vesicle, also called the pallium, give rise to the cerebral cortex. These
dorsal progenitor cells, termed radial glial progenitor cells (RGCs), are located adjacent
to the ventricle in the ventricular zone (VZ) (Malatesta P et al. 2000; Dehay C and H
Kennedy 2007) (Chapter 1; Figure 1). These RGCs produce three different types of cells:
More radial glia progenitor cells, differentiated neurons, and intermediate progenitor cells
(IPCs) that will form a second layer of cells further away from the ventricle called the
subventricular zone (SVZ) (Noctor SC et al. 2004; Gal JS et al. 2006; Dehay C and H
Kennedy 2007) (Chapter 1; Figure 1). These IPCs will divide once to several times
giving rise to more IPCs and ultimately neurons (Noctor SC et al. 2004; Dehay C and H
Kennedy 2007). Together the RGCs and the IPCs will give rise to all of the projection
(glutamatergic excitatory) neurons, in the cerebral cortex.
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Another striking feature of cerebral cortical development is that the normal sixlayered neocortex develops in a highly ordered manner. The first neurons to exit the cell
cycle and begin differentiation will migrate up away from the ventricle and begin to form
the cortex structure by residing in what will ultimately be the deepest layer of the cortex,
layer 6 (Frantz GD and SK McConnell 1996; Kandel ER et al. 2000). Subsequent
neurons migrate past layer 6 neurons and begin populating what will eventually be layer
5. This inside out process of development continues until neurons populate all six layers
(Frantz GD and SK McConnell 1996; Kandel ER et al. 2000). Glial cells that will
support the maturation and function of these neurons are subsequently produced from the
RGCs and will migrate up into all of the layers of the cortex (Bayer SA and J Altman
1991; Miller FD and AS Gauthier 2007). The outer most layer, known as the molecular
layer or layer 1, is formed early in development from a unique population of neurons
known as Cajal-Rietzius cells. This layer is formed prior to the deeper layers when the
RGCs are still clonally proliferating. The Cajal-Rietzius cells help to direct the migration
of the other neurons and glia into their appropriate layers (Meyer G et al. 2002; Hevner
RF et al. 2003; Takiguchi-Hayashi K et al. 2004; Bielle F et al. 2005; Soriano E and JA
Del Rio 2005).
There is currently some controversy regarding which cortical layers the IPCs
contribute neurons to. As was previously described IPCs are produced by the RGCs
early in development and they, in turn, replicate themselves and ultimately differentiate
into neurons but not glia. Some evidence exists to support IPCs producing excitatory
neurons that will reside in all layers of the cortex. Other evidence suggests that IPCs
only produce superficial or upper layer neurons (for review see (Kriegstein A et al. 2006;
3

Pontious A et al. 2008)). The upper layer neuron hypothesis is supported mainly by the
fact that upper layer molecular markers (Cux1, Satb2, Cux2, Svet1) are expressed in IPCs
both before and during neurogenesis of upper layer neurons (Tarabykin V et al. 2001;
Nieto M et al. 2004; Zimmer C et al. 2004; Britanova O et al. 2005). The IPCs reside in
and form the SVZ during the time when the upper layer neurons are being generated.
Thus the timing is right for the IPCs to give rise to upper layer neurons and not lower
layer neurons (Takahashi T et al. 1999; Gotz M and L Sommer 2005). However, there is
also evidence that IPCs during development produce neurons from all neocortical layers
even before the SVZ is formed (Kowalczyk T et al. 2009). There is currently no direct
evidence that IPCs produce only upper layer neurons versus neurons in all layers, thus
this point remains to be experimentally determined.
There are more than excitatory neurons in the neocortex. Inhibitory neurons, or
interneurons, comprise twenty percent of the adult neuronal population of the cerebral
cortex, and are derived from a completely separate progenitor source (Faux C et al. 2010;
Le Magueresse C and H Monyer 2013). These cortical interneurons develop ventrally in
the subpallial compartment of the telencephalon in three regions known as the caudal,
medial, and lateral ganglionic eminences (Chapter 1; Figure 1). They are embryonic
structures located in what ultimately is the region of the basal ganglia in the adult
(Wonders C and SA Anderson 2005; Marin O 2013). Analogous to the dorsal
telencephalon, the medial ganglionic eminence progenitor cells will first divide to self
replicate and later in development, beginning around embryonic day 10.5, they will begin
to produce differentiated premature interneurons (Ross ME 2011; Le Magueresse C and
H Monyer 2013). These developing interneurons will migrate dorsally up into the cortex
4

at the same time that the excitatory neurons are being produced by the RGCs and
migrating radially to form the layers of the cortex (Faux C et al. 2012; Kwan KY et al.
2012; Marin O 2013) (Chapter 1; Figure 1). The interneurons integrate into the forming
cortex in the same inside out manner as the excitatory neurons with the first interneurons
populating the deeper layers and the last ones populating the most superficial layers
(Miyoshi G and G Fishell 2011; Faux C et al. 2012; Kwan KY et al. 2012).
Once both the excitatory neurons and the interneurons have reached their final
destinations they begin to send out axons to make connections with other neurons
(Kandel ER et al. 2000; Lagercrantz H and T Ringstedt 2001). The excitatory neurons
will make connections with adjacent neurons, neurons in other layers of the cortex,
neurons in other neocortical regions, or send projections to other subcortical regions
(Kandel ER et al. 2000; Innocenti GM and DJ Price 2005; Price DJ et al. 2006). The
interneurons will primarily make local connections with neighboring cortical neurons
since they are responsible for the coordination and regulation of cortical-cortical circuits
(Kandel ER et al. 2000; Woo NH and B Lu 2006). After the axons have found their
correct targets they will form synapses on the dendrites of other neurons to form complex
circuits. Synapses are strengthened by activity and lost if inactive, a process called
pruning (Kandel ER et al. 2000; Lagercrantz H and T Ringstedt 2001; Innocenti GM and
DJ Price 2005). Through these processes the early brain is wired.
The cerebral cortex is organized into columnar functional units and groups of
these units are then further organized into functional modules that control different tasks
such as motor control or vision (Sansom SN and FJ Livesey 2009). Within any column of
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cortex from the pial surface, the outer surface of the brain, to the ventricle the cells all
have connections to each other and will all be activated together (Kandel ER et al. 2000;
Sansom SN and FJ Livesey 2009). It is hypothesized that all of the cells born from a
single RGC may form a column together (Kornack DR and P Rakic 1995; Sansom SN
and FJ Livesey 2009). Within each column the cells in each layer make particular types
of connections. In general the excitatory neurons in layers 2 and 3 project locally and to
the opposite side of the cortex across the white matter tract called the corpus callosum
with their axons terminating in layer 4 of the contralateral cortex (Kandel ER et al. 2000;
Thomson AM and C Lamy 2007; Sansom SN and FJ Livesey 2009). Layer 4, which is
the primary input layer to the cortex, also receives inputs from the thalamus. Neurons in
the deeper layers, 5 and 6, primarily project to layer 1 or layer 6, but these are feedback
projections rather than feed-forward (Kandel ER et al. 2000; Thomson AM and C Lamy
2007; Sansom SN and FJ Livesey 2009). Neurons in layer 5 predominately project out of
the cortex to subcortical regions including down the spinal cord (Kandel ER et al. 2000;
Thomson AM and C Lamy 2007; Sansom SN and FJ Livesey 2009).
Neuronal development disorders
Mutations in a variety of genes can disrupt any or all of these developmental
processes and result in a spectrum of conditions. Some mutations lead to structural brain
malformations while other mutations alter the circuitry, synapses, or function and lead to
intellectual disability, and epilepsy. Genetic studies in a host of different brain
malformations has led to the discovery of genes involved in regulating proliferation,
migration, and cortical organization, among a host of other processes. Mutations have
6

been identified in genes involved in transcriptional regulation, cell cycle regulation,
centrosome maturation and duplication, spindle formation, and DNA repair cause
changes in proliferation and apoptosis of cortical progenitor cells (Barkovich AJ et al.
2012). These mutations lead to malformations such as microcephaly (small brain with
fewer neurons) megalencephalies (large brain with more neurons), and focal or diffuse
dysgenesis (areas of increased or decreased cortex size) (Manzini MC and CA Walsh
2011; Barkovich AJ et al. 2012).
Mutations in genes involved in structural and regulatory components of the
cytoskeletal and the centrosome can cause problems with initiation, progression, and
direction of migration. This leads to malformations such as periventicular heterotopia
(problems with initiation of migration resulting in disorganized groups of neurons at the
ventricle), subcortical heterotopia (problems with the direction of migration resulting in
disorganized groups of neurons in the white matter), lissencephaly (problems with
continuation and direction of migrations which results in a loss of the normal gyrated
surface, a thickened neocortex, and a smooth brain), polymicrogyria (multiple small
gyri), and cobblestone malformations (an overmigration of neurons resulting in
disorganized groups of neurons at the pial surface of the brain) (Manzini MC and CA
Walsh 2011; Barkovich AJ et al. 2012).
Mutations in genes involved in neuronal specification, projection, and the
formation of synapses can cause changes in cortical organization and function. This leads
to malformations such as focal dysplasia (areas of layer disorganization) and some
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instances of polymicrogyria (multiple small gyri) (Manzini MC and CA Walsh 2011;
Barkovich AJ et al. 2012).
The role of Arx in cortical development
Several genes do not fit neatly into any of these categories. One example is the
Aristaless-related homebox gene (ARX/Arx), which is a transcription factor that is
expressed in the developing hypothalamus, thalamus, basal ganglia, and cerebral cortex.
It appears to regulate proliferation, specification, migration, and differentiation of various
populations of neurons in these areas of the brain (Marsh ED and JA Golden 2012). Arx
is on the X-chromosome thus most ARX patients are male as one normal allele is
sufficient for normal brain development. There are currently 44 different mutations of
ARX that have been found in humans (Shoubridge C et al. 2010) (Chapter 1; Figure 2).
These mutations cause a spectrum of phenotypes from lissencephaly and
hydranencephaly to mutations that cause no brain malformations, but do lead to
intellectual disability and epilepsy.
One explanation for the different phenotypes associated with different mutations
of the same gene is that mutations in different parts of the gene affect the function of the
gene in different ways. In the case of ARX, more severe patient phenotypes, those that
have brain malformations such as lissencephaly, are the result of either complete loss of
function of the gene (deletions or truncations) or from mutations in the homeodomain
region of the gene, which prevents Arx from to binding to DNA (Chapter 1; Figure 2).
Point mutations and missense mutations that do not occur in the homeodomain tend to
result in milder phenotypes that rarely include structural brain anomalies, but do include
8

moderate intellectual disability and epilepsy (Chapter 1; Figure 2). The exception to this
rule is the polyalanine expansion mutations in the second polyalanine tract. These are the
most common type occurring in about 40% of patients with an ARX mutation
(Shoubridge C et al. 2010). These mutations can result in patients with a spectrum of
phenotypes such as mild intellectual disability, moderate intellectual disability and
dystonic hand movements (Parrington syndrome), moderate intellectual disability and
infantile spasms, a particular type of epilepsy (West syndrome), or severe intellectual
disability and early onset tonic spasms (Ohtahara syndrome) (Shoubridge C et al. 2010)
(Chapter 1; Figure 2).
In order to look at the role of Arx in brain development and how mutations in this
gene can lead to this pleiotropy of phenotypes in humans a mouse with no Arx expression
(Arx-/Y) was created in 2002. This Arx-/Y mouse dies shortly after birth most likely due to
seizures or an inability to feed (Kitamura K et al. 2002). These mice have a thinner
cortex and decrease proliferation in the cortex during development, but migration of the
post mitotic excitatory neurons into the cortex seemed to be relatively normal (Kitamura
K et al. 2002). The Arx-/Y mice also have abnormal nerve fiber tracts such as the corpus
callosum, thalamo-cortical tract, fimbria, and hippocampal commissure (Kitamura K et
al. 2002). In addition, the Arx-/Y mice have deficiencies in interneuron migration into the
cortex and this led to mislocalization of interneurons in the cortex in addition to a loss of
particular subtypes of interneurons (Kitamura K et al. 2002).
Mutant mice have also been generated with a series of ARX mutations seen in
human patients (Kitamura K et al. 2009; Price MG et al. 2009). Two of the mutations are
9

point mutations in the homeodomain (P353L and P353R) and two others are expansions
in the first polyalanine tract (330ins(GCG)7) and (10+7(GCG)) (Kitamura K et al. 2009;
Price MG et al. 2009). In humans these mutations all produce very different phenotypes;
the P353L mutation results in myoclonic epilepsy and intellectual disability, the P353R
mutation results in XLAG (x-linked lissencephaly with ambiguous genetalia), and the
polyalanine expansion results in West syndrome (infantile spasms and intellectual
disability) (Kitamura K et al. 2009). Mice harboring the P353R (ArxPR/Y) mutation die
shortly after birth and have small brains similar to Arx-/Y mice (Kitamura K et al. 2009).
Also similar to Arx-/Y mice, they have thinner cortices a loss of upper layer neurons, and
an expansion of deeper layer neurons (Kitamura K et al. 2009). The ArxPR/Y mice also
showed very little migration of interneurons into the cortex. Therefore, this mouse seems
to be a good model of its human mutation and since it is similar to the Arx-/Y mouse, the
Arx-/Y mouse can also be used as a model for human patients with these types of
mutations.
The P353L knock-in mice (ArxPL/Y) and the polyalanine expansion mice
(Arx(GCG)7/Y) have normal sized brains and cortices and with no change in cell layers
(Kitamura K et al. 2009). Both the ArxPL/Y mice and the Arx(GCG)7/Y mice have delayed
migration of their interneurons into the cortex and the ArxPL/Y mice have a slight
reduction of interneurons in the cortex and the Arx(GCG)7/Y mice have a more severe
reduction of interneuron numbers (Kitamura K et al. 2009). Most of the Arx(GCG)7/Y mice
have seizures and die by around three months of age while the ArxPL/Y mice have a
normal lifespan and did not have seizures, but did have a lower threshold when
challenged with seizure inducing drugs (Kitamura K et al. 2009). In addition to their
10

more severe seizure phenotype the Arx(GCG)7/Y mice also have a more severe behavioral
phenotype than the ArxPL/Y mice. The Arx(GCG)7/Y mice showed impaired aversive, spatial,
and procedural learning whereas the ArxPL/Y mice only showed impaired aversive and
spatial learning. In addition the Arx(GCG)7/Y mice were also anxious and hyperactive and
the ArxPL/Y mice were not (Kitamura K et al. 2009). While recognizing these mice are not
perfect models of the human phenotypes they do seem to mirror the severity of the
human phenotypes. This indicates that the impairments to the function of Arx in each
mutation is probably similar between mice and humans and therefore these mice are a
reasonable model to further study the function of ARX and ARX mutations in patients.
A second polyalanine tract expansion mouse was made by again inserting 7
(GCG) codons inserted similar to the other polyalanine tract expansion mouse, but in a
different location in the polyalanine tract (Arx(GCG)10+7) (Price MG et al. 2009). These
mice exhibit a similar behavioral and morphological phenotype to the Arx(GCG)7/Y mice.
One exception to this is that the Arx(GCG)10+7 mice were found to be less anxious and not
hyperactive which is the opposite of the Arx(GCG)7/Y mice (Price MG et al. 2009). These
mice (Arx(GCG)7/Y) were shown to have seizures with similarities to the infantile spasms
observed in human patients as early as nine days of age (Price MG et al. 2009). The
Arx(GCG)7/Y mice also displayed social deficits in the social dominance tube test (Price MG
et al. 2009). This second polyalanine tract expansion mouse (Arx(GCG)7/Y) confirms that
mouse models of human ARX mutations can be made and can serve as models for the
human disease.
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Arx mutant mice and human ARX patients have defects in many parts of their
brains, but also in other parts of their bodies which led scientists to investigate where Arx
is expressed during development and in the adult. Arx is first expressed in the anterior
neural plate before neural tube closure. After neural tube closure it is expressed in the
neural stem cells lining the bulges that will become the telencephalon (Colombo E et al.
2004). As development proceeds its expression can be found in the ventral thalamus, the
floorplate of the developing spinal cord, the myotome which will give rise to the body
muscles, the pancreas, the stomach, and the testes (Colombo E et al. 2004). In adults Arx
expression is restricted to interneurons in the cerebral cortex and the olfactory bulb and
adult neural stem cells (Colombo E et al. 2004).
In the developing cerebral cortex Arx shows distinct expression patterns in
different neuronal populations. Arx is expressed in the medial ganglionic eminence, an
embryologic structure in the ventral telencephalon is the origin of cortical interneurons
(Kitamura K et al. 2002). Cortical interneurons are physiologically inhibitory and play
central roles in modulating activity in cortical-cortical circuits. Arx expression begins in
these neurons as they become post mitotic and begin migrating and continues to be
expressed in the mature interneurons (Kitamura K et al. 2002; Colombo E et al. 2004).
Arx is also expressed in the dorsal telencephalic region that gives rise to
projection (excitatory) neurons. Expression is observed in the cortical progenitor cells
and intermediate progenitor cells (VZ and SVZ respectively) as the cells are proliferating
to generate the excitatory neurons and the glia cells that will populate the cerebral cortex
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(Colombo E et al. 2004). However, in contrast to the interneuron population, Arx is
downregulated as these cells become post mitotic and begin to migrate.
Thus far much of the work on Arx in the brain has focused on its role in
interneuron development with less focus on its role in the cortical progenitor cells. A
conditional knockout mouse was engineered with floxed sites around exon 2, which
contains the first part of the homeodomain (Fulp CT et al. 2008). This mouse has been
used to remove Arx specifically from the developing interneurons (Arx-/Y Dlx5/6Cre)
(Marsh E et al. 2009). Male Arx-/Y Dlx5/6Cre mice all had abnormal background EEGs
and spontaneous seizures, which suggests that loss of Arx in the interneurons is sufficient
to cause epilepsy and could be the pathogenesis in human patients (Marsh E et al. 2009).
Unexpectedly, half of the female heterozygous Arx-/X Dlx5/6Cre mice had seizures
and abnormal background EEGs, which is consistent with the theory that random X
inactivation would cause some females to be more severely affected than others (Marsh E
et al. 2009). In humans most ARX patients are males, since ARX is on the Xchromosome, and their mothers are carriers and have a normal phenotype though some of
them have agenesis of the corpus callosum (Marsh E et al. 2009). However, when other
female relatives of the male patients are examined two thirds of them were found to have
some type of neurological symptoms (Marsh E et al. 2009). This would suggest that
perhaps the mothers of the ARX patients might have skewed X-inactivation such that the
majority of their cells are expressing the X with the normal ARX allele and the other
female relatives either have normal X-inactivation or X-inactivation skewed towards
expression of the mutant ARX allele. However, when the X-inactivation studies were
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conducted in these female relatives skewed inactivation was not observed (Marsh E et al.
2009).
Other research on the role of Arx in interneurons has focused on both how it is
regulated and what genes it regulates. In interneurons Arx expression is regulated by the
transcription factors Dlx1 and 2 (Cobos I et al. 2005; Colasante G et al. 2008). Arx then
regulates many genes involved in migration during early development, such as Cxcr7 and
Cxcr4 (chemokine receptors used to direct migration) and specification, such as Magel2
(Fulp CT et al. 2008; Colasante G et al. 2009; Friocourt G and JG Parnavelas 2011).
Later during interneuron development Arx regulates genes involved in axonal projection,
such as Slt2 and Sema6a (ligands involves in axon guidance) (Fulp CT et al. 2008;
Colasante G et al. 2009; Friocourt G and JG Parnavelas 2011). Two microarrays have
been done on Arx deficient developing interneurons, but so far only 3 genes (Lmo1, Ebf3,
and Shox2) have been shown to be direct targets of Arx in interneurons (Fulp CT et al.
2008). Only one of these genes (Ebf3) has been shown to be necessary for the migration
of interneurons (Colasante G et al. 2009).
Both of these microarrays provide in vivo support for the theory that Arx
primarily acts as a transcriptional repressor since the majority of genes found were
upregulated in the Arx deficient interneurons (Fulp CT et al. 2008; Colasante G et al.
2009). The array experiments confirmed earlier in vitro data demonstrating that Arx acts
as a transcriptional repressor and binds to Groucho/transducin-like enhancer of split
(TLE) proteins (McKenzie O et al. 2007). Several recent studies have begun to explore
how different mutations of Arx can change its ability to regulate the transcription of
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particular genes. Arx protein, which has a polyalanine tract expansion mutation similar
to those seen in ARX patients, is still capable of binding to DNA but fails to repress some
of the genes that it can normally repress (Nasrallah MP et al. 2012). Arx with the
polyalanine tract expansion fails to repress Ebf3 or Shox2, but still represses Lmo1 in
cells and knock in mice with this mutation (Nasrallah MP et al. 2012). This appears to be
due to the fact that Arx with the polyalanine tract expansion mutation can no longer bind
to its cofactor Tle1 and therefore can no longer repress a subset of its target genes
(Nasrallah MP et al. 2012). Another study found that most point mutations in the
homeodomain of Arx, which result in the most severe human phenotypes, fail to repress
Lmo1 and Shox2 and fail to bind to DNA (Cho G et al. 2012; Shoubridge C et al. 2012).
In addition point mutations in the nuclear localization signal of Arx also appear
mislocalized to the cytoplasm (Shoubridge C et al. 2012). There is also some evidence
that the binding of different proteins to Arx could change its affinity for particular DNA
binding sites (Cho G et al. 2012). Together, these data begin to provide some insight into
why different mutations of ARX can result in such different phenotypes.
Even though the Arx-/Y mice had defects in the development of both the excitatory
projection neurons and the inhibitory interneurons in the cortex. Most of the research in
the field has focused on the role of Arx in interneurons and its role in cortical progenitor
cells has been less extensively studied. One exception to this is a study, which examined
the role of Arx in the progenitor cells in the cortex using in utero electroporated plasmids
containing either an shRNA against Arx or an overexpression of Arx into the embryonic
mouse brain at embryonic day 13.5 (Friocourt G et al. 2008). When Arx was inactivated
with the shRNA construct fewer transfected cells were found in the VZ of the cortex and
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fewer of them were mitotic. In contrast, when Arx was overexpressed there were more
transfected cells in the VZ of the cortex and more of them are stuck in the cell cycle with
a longer synthesis phase of the cell cycle and a longer overall cell cycle length (Friocourt
G et al. 2008). In addition, when Arx was either inactivated or overexpressed using these
constructs in utero the migration of the excitatory cells into the cortex was disrupted such
that they did not reach the cortex as quickly and had abnormal morphology during
migration (Friocourt G et al. 2008).
This paper further supported the hypothesis that Arx plays a role in regulating
proliferation and possibly radial migration in the development of the excitatory cells of
the cortex. However, the design of their experiments makes several of the results
difficult to interpret. By only observing one time point during development and knocking
down or overexpressing Arx after cortical development has already begun there is no way
to know if Arx has a role earlier in development or how the partially developed cortex
may impact the later loss of Arx. As they did not follow any of the electroporated pups
through to postnatal times we do not know if the radially migrating excitatory neurons are
completely inhibited from reaching the cortex or whether they are simply delayed.
Another problem with these experiments is the lack of specificity in the transfections or
analysis of the transfected cells. It is assumed only VZ cortical progenitor cells are
transfected, without confirmation. Since Arx expression is only altered mid way through
development and only some progenitor cells are altered these experiments do not
recapitulate well the dysfunction of mutant ARX in developing human brain.
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To better analyze the role of Arx in the progenitor cells of the cortex and examine
how loss of Arx in these cells affects cortex development and function we took advantage
of our floxed allele to remove Arx from the cortical VZ (Fulp CT et al. 2008). To do this
we mated our Arx floxed mice (ArxF/X) to Emx1Cre mice. Emx1 is a transcription factor
that is expressed in the dorsal part of the developing telencephalon starting at embryonic
day 9.5 of development. Mating these mice together produced male mice with no Arx
expressed in their cortical progenitor cells during development, but preserved Arx in the
interneuron precursors. We then assayed proliferation, cell cycle dynamics, and cortical
layer formation in late stage embryogenesis and adult mice. We also identified a possible
cell cycle regulatory gene that could be repressed by Arx in order to control cortical
progenitor cell proliferation and differentiation and thereby control cortical layer
formation. Finally, we examined the behavioral phenotype of these mice in order to
determine what role the cortical malformations verses the loss of interneurons plays in
the patient phenotypes. This research has led to a better understanding of the role Arx
plays in cortical development and it has also led to a better understanding of how
mutations in Arx cause the behavioral deficits seen in human patients.
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Figure 1: Cortical interneurons arise in the ventral telencephalon and migrate up into the
cortex (blue arrow), while the excitatory neurons arise in the dorsal telencephalon and
migrate out into the cortex (red arrows). The excitatory neurons come from two types of
progenitor cells the radial glia cells (red) and intermediate progenitor cells (orange). Radial glia
cells can divide to give rise to more of themselves, they can divide to produce differentiated
neurons which will migrate out into the cortex, or they can divide to produce intermediate
progenitor cells. Intermediate progenitor cells divide to give rise to more of themselves and to
differentiated neurons.
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Figure 2: Schematic of the ARX protein showing the functional domains of the protein and
the locations of different mutations seen in patients. ARX (Aristaless related homeobox
transcription factor) has an aristaless (Arist) domain at it C-terminal, an octapeptide (OP) domain
at its N-terminal, a homeodomain which binds to DNA surrounded by nuclear localization signals
(NLS), and four polyalanine tracts (PA). The most severe mutations of ARX, which result in
brain malformations; such as XLAG (X-linked lissencephaly with ambiguous genitalia), HYDAG (hydranencephaly with ambiguous genitalia), and Proud syndrome are caused by deletions
(Del), frameshifts (fs), and point mutations in the homeodomain. Less severe mutations of ARX,
which result in epilepsy and intellectual disability syndromes; such as Ohtahara, IEDE (idiopathic
infantile epileptic dyskinetic encephalopathy), West syndrome, XMESID (X-linked myoclonic
seizures, spasticity and intellectual disability), Partington syndrome, and non-specific X linked
intellectual disability (XID) are caused by expansions of the polyalanine tracts and by point
mutations elsewhere in the gene.
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CHAPTER 2: ARX regulates cortical intermediate progenitor cell expansion and
upper layer neuron formation through repression of Cdkn1c

Introduction
Mutations in the Aristaless-related homeobox gene (ARX) are a common cause of
X-linked intellectual disability. Over 40 different mutations have been identified in ARX
resulting in a spectrum of disorders that vary from mild intellectual disability with no
brain malformations to severe brain malformations such as lissencephaly and
hydranencephaly (Gecz J et al. 2006). Currently the pathogenesis of these ARX related
disorders are poorly defined.
During mouse cerebral cortical development Arx is expressed in the ventricular
zone (VZ) (Colombo E et al. 2004; Friocourt G et al. 2006; Colasante G et al. 2008). Arx
deficient mice die shortly after birth with a thin and disorganized neocortex in addition to
other brain abnormalities (Kitamura K et al. 2002). The neocortical alterations appear to
be the result of decreased pallial progenitor cell proliferation (Kitamura K et al. 2002;
Friocourt G et al. 2008). However, it remains unclear how Arx regulates cortical
progenitor cell proliferation, cell specification and layer formation in the neocortex.
To define the endogenous function of Arx in the cortical VZ, Arx floxed mice
were mated to Emx1Cre mice, removing Arx specifically in the dorsal telencephalon. The
number and proliferation rate of progenitor cells, their cell cycle length, and final cortical
laminar fate were then assayed. Our data show that Arx regulates the expansion of both
radial glial cells (RGC) and intermediate progenitor cells (IPC), with a more pronounced
effect on the latter. The decrease in proliferation in the Arx cKO mice resulted in a loss
of neurons specifically in the upper layers of the neocortex. This is consistent with the
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hypothesis that IPC derived neurons contribute to all cortical layers, but predominately
upper layers (Tarabykin V et al. 2001; Nieto M et al. 2004; Zimmer C et al. 2004; Sessa
A et al. 2008).
We also identified a cohort of genes whose expression is consistently altered in
Arx KO mice cortices when compared to wild type mice. Among them, Cdkn1c,
encoding for CDKN1C, was found to be a direct target and its role in the identified IPC
phenotype was analyzed. As a member of the Cip/Kip family of cyclin dependent kinase
inhibitors (CDKi), CDKN1C antagonizes cell cycle progression by inhibiting G1/S
transition (Sherr CJ and JM Roberts 1999). Interestingly, CDKN1C, whose expression is
normally detected in the cortical SVZ, was overexpressed in both the VZ and SVZ of Arx
KO cortices. Thus, ARX appears to regulate cortical progenitor pool expansion by
repressing the premature expression of Cdkn1c in the cerebral cortex.

Methods
Mice
Arx conditional knockout mice (Arxfl/fl) (Fulp et al., 2008) and Arx knockout mice
(Arx-/y) (Collombat P et al. 2003) were maintained on a C57Bl/6 background. Timedpregnant mice were considered embryonic day 0.5 (E0.5) on the morning of the
confirmation of the vaginal plug. To inactivate Arx in the dorsal telencephalon during
development Arxfl/y mice were crossed with Emx1Cre animals (Jin XL et al. 2000).
Genotyping of Arx conditional knockout and germline knockout mice was performed as
described (Jin XL et al. 2000; Collombat P et al. 2003; Fulp CT et al. 2008).
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Tbr2::GFP transgenic mice (Kwon GS and AK Hadjantonakis 2007) were crossed
with Arxfl/y; Emx1Cre animals. Mice were maintained at the Children’s Hospital of
Philadelphia and at the San Raffaele Scientific Institute Institutional, lab animal facilities.
All experiments were approved by the Institutional Animal Care and Use Committees of
the Children’s Hospital of Philadelphia and of San Raffaele Scientific Institute, Milan.
BrdU administration for cell cycle dynamic analysis
BrdU was administered (50 mg/kg, i.p.) to pregnant mice 1 h before embryo
harvesting to assess the S-phase labeling index. A cumulative BrdU labeling protocol
was followed to determine the growth fraction (GF) (fraction of the cell population that is
proliferative), to determine the time to reach the growth fraction (Tc − Ts), and,
subsequently, to estimate the length of the cell cycle (Tc) and the duration of S-phase
(Ts) for both radial glia and intermediate progenitors (Takahashi T et al. 1995). Pregnant
mice were injected with BrdU (50 mg/kg, i.p.) starting at E13.5, with injections every 3
hours and with survival times of 0.5 h. Thus, a total of six time points were examined:
0.5 h, 3.5 h, 6.5 h, 9.5 h, 12.5 h and 15.5 h. For cell cycle exit experiment, BrdU (50
mg/kg, i.p.) was injected in a pregnant female at E13.5 and 24 hours later embryos were
harvested and processed for analysis.
Histological techniques
Nissl staining
Sections were stained in a 0.1% cresyl violet solution for 5-10 minutes and then,
rinsed quickly in distilled water. Thereafter, sections were dehydrated in 100% ethanol
(2x5 min), dried and coverslipped with Eukitt (Electron Microscopy Science).

22

RNA in situ hybridizations
ISH on frozen sections was performed as previously described by (SchaerenWiemers N and A Gerfin-Moser 1993) with the modifications previously reported
(Colombo E et al. 2007). Cdkn1c in situ probe was a kind gift of Dr. L. Muzio (Muzio L
et al. 2002).
Immunohistochemistry
Whole heads (E11.5 and E12.5) or brains were dissected from embryonic and P1
mice and fixed over night in 4% PFA at 4°C. P14 and P30 mice were perfused with 4%
PFA and then the brains were removed and fixed in 4% PFA overnight at 4°C. Fixed
brains were frozen and 10um-thick coronal section were obtained. Antigen retrieval was
performed in citric acid-based Antigen Unmasking Solution (Vector Laboratories)
autoclaved at 105 °C for 10 minutes and BrdU staining where slides were treated with 2N
HCl for 20 minutes. No antigen retrieval was performed for ARX and TBR2. Sections
were then blocked for 1 hour at room temperature with 10% normal goat serum (Gibco)
and 0.1% triton in PBS. Primary antibodies against ARX (rabbit, gift kindly provided by
Professor Kunio Kitamura, 1:500), KI67 (rabbit, Immunological Sciences, 1:300 and
mouse, BD Pharmingen, 1:200), BrdU (rat, Accurate Chemical and Scientific, 1:200),
PH3 (rabbit, Chemicon, 1:100), TBR2 (rabbit, Abcam, 1:200 and Chemicon, 1:300),
PAX6 (mouse, Developmental Studies Hybridoma Bank, 1:1000), CUX1 (rabbit, Santa
Cruz Biotechnology, 1:50), SATB2 (mouse, Bio Matrix Research, 1:200), CTIP2 (rat,
Abcam and Beckton-Dickinson 1:300), GFP (chicken, 1:2000), Caspase3 (rabbit, Cell
Signaling, 1:200), and TBR1 (rabbit, Abcam, 1:25 and Chemicon, 1:400) were diluted in
10% normal goat serum and incubated on slides overnight at 4 °C. Secondary antibodies
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were conjugates of Alexa Fluor 488, Alexa Fluor 594, and Alexa Fluor 647 (1:500,
Invitrogen), biotinylated goat anti-mouse and anti-rabbit (Dako, 1:100). They were
diluted in 10% normal goat serum and incubated on slides for 2 hours at room
temperature. Biotinylated secondary antibodies were subsequently incubated with
strepdavidin-Cy3 (Jackson ImmunoResearch, 1:300) in PBS. Slides were then
counterstained with DAPI (Invitrogen, 1:1000), washed and mounted in Fluorescent
Mounting Medium (DakoCytomation).
For the ARX/TBR2 double labeling, sections were blocked in 10% normal
donkey serum (Jackson ImmunoResearch) with 0.3% triton in TBS (Tris buffered saline
pH 7.4, USB Cleveland, OH; the buffer used throughout the procedure) for 30 minutes at
room temperature. Anti-TBR2 antibody (Abcam, 1:200) in 10% donkey serum next was
applied for 2 hours at room temperature followed by washing with TBS and then
incubation with goat anti-rabbit monoclonal Fab fragments (Jackson ImmunoResearch,
1:25) in 10% donkey serum for 30 minutes at room temperature. They were then washed
and secondary Alexa 594 donkey anti-goat 1:200 in 10% donkey serum in TBS was
applied for 30 minutes at room temperature. For the second primary antibody the
sections were again washed and blocked with the goat anti-rabbit monoclonal Fab
fragments 1:25 in 10% donkey serum. After washing the anti-ARX antibody was applied
overnight at 4 °C in 10% donkey serum. Finally the slides were washed and the
secondary Alexa 488 donkey anti rabbit was applied at 1:200 in 10% donkey serum for
30 minutes at room temperature. The slides went through on final wash, were
counterstained with DAPI and mounted.
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Quantifications and statistical analysis
All quantifications on P14 cryostat brain sections were performed using a 200µm
section of the dorsomedial cortex at the mid-hemispheric level from pia to white matter.
For quantifications on E11.5 and P1 brain sections, cell counts were derived from 25% of
the neocortex. The area of interest was derived by measuring the linear distance along
the pial and ventricular surfaces of the entire lateral cortex, dividing those into quarters,
and then using the total area, from pia to ventricle, in the third quartile from the dorsal
midline. Quantifications on E14.5 brain sections were performed using a 150µm section
of the dorsomedial and lateral cortex. At least three serial sections from three different
animals for each genotype were photographed using a Leica DMR fluorescent
microscope. Images were imported into Photoshop CS3 and double-positive cells were
overlaid manually by color-coded dots in new layers. The number of labeled cells (dots)
was calculated using the Record measurements of Photoshop CS3 and imported into
Excel 2008. The percentage of labeled cells per region per section was calculated for
each brain, and the final mean percentage calculated across all brains. Results were
expressed as mean value ± SD and were tested for statistical significance by the two
tailed, unpaired Student's t test (p < 0.05 level of significance).
RNA isolation, processing, and microarray analysis
The experiment was performed as previously described (Colasante G et al. 2009).
Briefly, 3 pregnant Arx heterozygous dams crossed with C57Bl/6 males were sacrificed
at E14.5. A total of 5 wt and 5 Arx KO embryos were harvested and after brain isolation
the cerebral cortices were separated from the ventral telencephalon. Total RNA was
extracted from the cortices using the Qiagen RNA micro kit (Qiagen, Valencia, CA).
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cRNAs were generated and hybridized on a total of ten different MOE430v2 Affymetrix
DNA chips according to the Affymetrix protocol. The chips were scanned with an
Affymetrix scanner to generate digitized image data files. The data were deposited in the
NCBI Gene Expression Omnibus (Edgar R, Domrachev M, Lash AE. Gene Expression
Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids
Res. 2002; 30:207–10) and are accessible through GEO Series (# GSE12956).
Luciferase reporter assays
P19 cells (105) were seeded and transfected 24 h after plating with 400 ng of each
of the following constructs in different combinations: pT81 luciferase reporter plasmids,
control plasmid pCAG-iresGFP, pCAGArx-iresGFP, pCDNA3-Tle1 and 80 ng of pRLTK-Renilla luciferase plasmid DNA (Promega) using Lipofectamine PLUSTM Reagent
(Roche Diagnostics, Alameda, CA). Forty-eight hours post-transfection, cell lysis and
measurement of firefly and Renilla luciferase activity was performed using the Dual-Glo
Luciferase Assay System (Promega) according to the manufacturer’s instructions. The
firefly luciferase activity was normalized according to the corresponding Renilla
luciferase activity, and luciferase activity was reported as mean relative to pCAGiresGFP/luciferase transfection. The two Cdkn1c -549/-68 and -1490/-720 enhancer
regions were PCR amplified from E14.5 mouse genomic DNA using the following
primers: HindIII-Cdkn1c-F1 5’- CCCAAGCTTGCGCGCGGGCCTCCTCAC-3’;
BamHI-Cdkn1c-R1 5’-CGCGGATCCCCAGGACCAGGACCCAGCTG-3’; HindIIICdkn1c-F2 5’- CCCAAGCTTGAGATCTAAAAGATCTGTAG-3’ and BamHI-Cdkn1cR2 CGCGGATCCTAGTGAATGAGGGGTTCATG-3’, respectively. The amplified
products were cut with HindIII and BamHI and cloned into the BamHI and HindIII sites
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of pT81-TK-Luciferase, which contains the thymidine kinase minimal promoter upstream
of luciferase. The (-549/-68) enhancer region carrying mutagenized ARX binding site
was generated by site-directed mutagenesis with the following primers 5’CTGAAAATACTACAGGATGCTCCTCGTGAGGAG-3’ and 5’CTCCTCACGAGGAGCATCCTGTAGTATTTTCAG-3’ using the QuikChange II sitedirected Mutagenesis Kit (Stratagene), according to the manufacturer’s instructions.
Chromatin immunoprecipitation
E14.5 mouse embryonic cortices were isolated and single-cell suspension derived
by enzymatic treatment. Cells were cross-linked with 1% formaldehyde for 10 min and
chromatin prepared essentially as described previously (Ferrai C et al. 2007; Colasante G
et al. 2008). The chromatin aliquots (1 ml) were incubated overnight with 1 µg of antiGFP (Chemicon) as mock and anti-ARX(C-14) (Santa Cruz). PCR primers used are the
following: PCR primers used are the following: ChIPEbf3-F, 5′GTCTATAAGTACAATGGTGACAC-3′; ChIPEbf3-R, 5′CTCCATCAAGATCCTTCTC-3′ (amplification product, 240 bp); ChIPCdkn1c-F, 5′GCGCCCCTTTATACGCGCTG 3′; ChIPCdkn1c-R, 5′TCACGTTACCGCCCGCAGAG-3′ (amplification product 200 bp); ChIPCdkn1a-F 5’GCTGTCAAAACGACCTTGAATG-3’; ChIPCdkn1a-R: 5’GGAAGGACTAACTCTTTTCCAG-3’ (amplification product 220 bp); ChIPCdkn1b-F
5’-CCCTGATAAGAGCGGTCAGTC-3’; ChIPCdkn1b-R 5’TTACGGAGCTTCGGTGGCTAG-3’ (amplification product 250 bp). PCR products
were analyzed on 2% agarose gels in TBE buffer.
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Results

Reduced cerebral cortex and olfactory bulbs after deletion of Arx from the dorsal
telencephalon
The germline loss of Arx in mice results in a thinner and disorganized cortex that
was attributed to a primary defect in cell proliferation (Kitamura K et al. 2002). To
further define the role of Arx in cortical progenitor cell proliferation we conditionally
deleted Arx from the E9.5 dorsal telencephalon by crossing our Arxfl/+ mice to Emx1Cre
mice (Jin XL et al. 2000) (Fig. 1A, B). In Arxfl/y; Emx1Cre mice (here after Arx cKO) no
ARX protein was observed in the VZ and SVZ of the cortex by E11.5 and throughout the
rest of development (Fig. 1A, B and data not shown). Morphological analyses performed
at E14.5 revealed that, at this developmental stage, alterations of the gross morphology of
Arx cKO brains are already evident. The cerebral hemispheres are reduced in size and
the olfactory bulbs are smaller and characterized by an abnormally wide interspace
separating them (Fig. 1C, D). Nissl staining on E14.5 coronal sections highlighted the
diminution of cortical thickness affecting Arx cKO cerebral cortex in its whole mediolateral extension (E14.5 relative volume (rv) Arx cKO/ctrl = 0.86±0.03; n=3, p < 0.005
(Fig. 1E, F, O). Arx-/y mice die perinatally (Kitamura K et al. 2002; Collombat P et al.
2003), whereas crosses between Arxfl/+ female and Emx1Cre male mice recovered all
expected genotypes in Mendelian ratios (data not shown). Morphological assessments at
P30 of Arx cKO and relative control brains confirmed the analysis made at E14.5.
Indeed, the cerebral hemispheres and olfactory bulbs in Arx cKO mice are reduced in
size, whereas the cerebellum and the brain stem do not appear to be affected (Fig. 1I, J).
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In addition, P30 Nissl stained coronal sections highlight an overall reduction of the
cerebral cortex, most evident at the level of pyriform cortex and the hippocampus (rv P30
= 0.84±0.05; n=3, p < 0.005) (Fig 1K, L, O).
In the Arx cKO the laminar structure cannot be clearly delineated (Fig. 1M, N)
and the corpus callosum was absent in Arx cKO brains (Fig. 1P, Q); this feature, together
with the microcephaly, strongly resembles the morphologic abnormalities observed in
patients with the XLAG syndrome (Kitamura K et al. 2002).
Our data indicate the loss of Arx in cortical progenitors recapitulates the
morphologic defects observed with the germline loss of Arx. These data support the
model by which the reduced brain size observed in Arx KO mice and children with loss
of function ARX mutations, is largely or completely due to a loss of Arx in cortical
progenitor cells.
Loss of Arx in the pallial progenitor cells reduces the proliferation rate of cortical
progenitor cells
Previous data suggested a decrease in cortical progenitor cell proliferation as the
basis for the reduced cerebral cortical thickness in Arx KO mice (Kitamura K et al. 2002).
At E11.5 in cortical development there are similar numbers of progenitor cells in wild
type and Arx cKO mice cortices as measured by the number of KI67 positive cells (ctrl:
392±33.5; cKO: 368±45.5, n=3, p=0.579: cells counted in 25% of the cortex from
ventricular to pial surface)(data not shown). This suggests normal numbers of cortical
progenitor cells exist early in development when the progenitor cells are being produced.
However, when the same analysis was performed at E12.5 we observed a reduction in the
percentage of proliferating progenitor cells (% KI67+/Hoechst, ctrl: 96.65±2.90; cKO:
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87.49%±5.58, n=6, p=0.016, cells counted in a 150 µm bin from the ventricular to the
pial surface)(Fig. 2C-D’, G) and an increase in ßIII-tubulin positive young neurons in Arx
cKO compared to control (% TUBB3+/Hoechst, ctrl: 10.88±2.96; cKO: 20.75±3.39, n=6,
p=0.003) (Fig. 2A-B’, H).
At E14.5 the cortical plate was already thinner (Fig. 1E, F) and the reduction in
the total number of proliferative cells was more evident in Arx cKO cortices (Fig. 3A, C)
(ctrl: 259±21.8; cKO: 202.5±16.3; n=6, p < 0.001, cells counted in a 150 µm bin from the
ventricular to the pial surface). Moreover, both the types of cortical progenitor cells RGCs and IPCs- are diminished in Arx cKO cortices at this embryonic stage. Indeed, we
observed a reduced PAX6 labeling intensity in Arx cKO mice (Fig. 3D’, E’) in addition
to a 27% reduction in the number of PAX6+ cells (ctrl: 323.6 ± 13.3; cKO: 237.5 ± 26.8;
n=3, p< 0.001; Fig. 3J) as well as a 20 % reduction of TBR2+ cells (ctrl: 223.6±16.4;
cKO: 179.3±10.8; n=3, p< 0.001)(Fig. 3F’, G’).
In order to exclude a contribution of an increase in cell-death to the reduction of
cortical thickness in Arx cKO cortices, the apoptotic marker Caspase3 was analyzed at
different embryonic stages (E13.5, E15.5, E17.5), finding no difference between Arx
cKO and relative controls (Fig. 4).
To determine if the reduction in proliferation was affecting both types of cortical
progenitor cells- RGCs and IPCs- in the same way, their rate of BrdU incorporation was
measured in control and Arx cKO cerebral cortices after a 1 hour BrdU pulse. As
expected, general reduction in BrdU incorporation (~24%) (arrows in Fig. 3F’’), was
found in Arx cKO cortices with respect to controls (ctrl: 142.3 ± 18.2; cKO: 109.0 ± 10.2;
n=3, p< 0.001 and Fig. 3J). Interestingly, double labeling with PAX6 and BrdU revealed
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little differences in the PAX6+/BrdU+ cell number between Arx cKO and control (ctrl:
125.6±19; cKO: 103.7±7.17; in both cases about 40% of the total PAX6+ cells; n=3,
p=0.012)(Fig. 3D’’’, E’’’, J). Conversely, double labeling with TBR2 and BrdU revealed
a reduction of dual labeled cells (ctrl: 52.9 ± 12.9, about 25% of the total TBR2+; cKO:
17.5 ± 2.9, about 10% of the total TBR2+; n=3, p< 0.001)(arrows in Fig. 3F’’’, G’’’, J).
Consistent with these data, staining with the M-phase marker phosphohistone 3 (PH3)
revealed an overall reduction of positive cells in the Arx cKO cerebral cortex with a
greater loss in the basal area (IPCs) than the apical area (RGCs) (apical, ctrl: 122.0 ± 5.6,
cKO: 107.5 ± 3.5; basal, ctrl: 39.0 ± 4.8; cKO: 11.5 ± 2.12 n=3, p< 0.001, Fig. 3H, I, H’,
I’, J).
Taken together, these data indicate that at E14.5 both progenitor populations
(RGCs and IPCs) are reduced in Arx cKO cerebral cortices and their proliferation is
affected. However, BrdU incorporation rates and PH3 staining indicate that there is a
disproportionate deficit in the proliferation of IPCs compared to RGCs in Arx cKO mice.
Cortical progenitors show a normal cell cycle length, but IPC mitoses are strongly
reduced in Arx cKO mice.
To further understand the mechanism by which loss of Arx resulted in fewer
proliferating cells, we tested two non-mutually exclusive hypotheses: that the cell cycle
changes are related to lengthening of the cell cycle or to precocious exit of cortical
progenitors from the cell cycle.
An increased cell cycle length during the neurogenic period would result in fewer
cellular divisions, fewer progenitor cells and the observed reduction in BrdU
incorporation. To examine neocortical cell cycle dynamics in the absence of Arx the
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length of the cell cycle phases was estimated between E13.5 and E14.5 in wild type and
Arx cKO mice using a cumulative BrdU pulse-labeling paradigm (Takahashi T et al.
1995). BrdU was injected intraperitoneally in gravid mothers every 3 hours up to 6 time
points with survival time being 0.5 hour after the last injection. At least 2 brains of each
genotype were assayed at each time point for BrdU labeling to evaluate the cell cycle
parameters in the VZ precursors, where VZ was defined by two criteria: the region under
the area with high density of TBR2+ cells and where cells with vertically oriented nuclei
were present. Moreover TBR2/BrdU double staining was performed in order to gain
information regarding the BrdU incorporation kinetic of IPCs. Representative cortical
fields of control and Arx cKO BrdU and TBR2 labeled coronal sections are shown for 5
out the 6 time points (Fig. 5A-J).
The growth fraction (GF) in the VZ - defined as the maximum percentage of VZ
progenitors entering the S-phase on the total of nuclei in the VZ - did not change between
the two genotypes, and in both cases almost 100% of VZ cells were BrdU+ at the 9.5 h
time point (Fig. 5G, H). The Labeling Index (LI) of VZ (BrdU+cells/total cell number) at
each time point was plotted against the corresponding time after BrdU injection and from
the slope of the interpolating lines, the cell cycle parameters Tc and Ts were calculated
(Fig. 5N, P). Interestingly, no significant difference was found in both parameters
between control and Arx cKO brains (ctrl: Tc=14.5 hrs and Ts= 4 hrs; cKO: Tc=14.1 hrs
and Ts= 4.1 hrs).
A similar analysis of the cell cycle kinetic was performed in the SVZ. First, the
GF at E13.5 was evaluated as the percentage of proliferating IPC (KI67+ TBR2+) on the
total of IPCs (TBR2+) (Fig. 5K-L’). Interestingly, while about the 75% of IPCs in the
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control were proliferating, only the 45% of cKO IPCs entered any cell cycle phase (%
KI67+ TBR2+/TBR2, ctrl: 74.30±1.99; cKO: 45.17±2.64, n=4, p<0.0004). Similar
reduction in the SVZ GF of Arx cKO was noticed also later on during cortical
development (Fig. 6; E17.5 % KI67+ TBR2+/TBR2, ctrl: 16.57±2.49; cKO: 7.58±0.26).
This result confirmed and completed the previous observations relative only to S and M
phases of the cell cycle.
Then, LI in the SVZ was calculated as the ratio between the TBR2+ cells
incorporating BrdU on the total of TBR2+ proliferating cells (BrdU+ TBR2+/Ki67+
TBR2+) and plotted against the corresponding time after BrdU injection and interpolating
lines generated for both control and Arx cKO (Fig. 5A’’-J’’, O). The slope of the Arx
cKO interpolating line resulted slightly higher, indeed cKO IPCs seemed to reach the
value of GF=1 a little before the control (Tc-Ts, control: 7.8h; cKO: 6.3h). As a
consequence, Tc and Ts resulted a little bit shorter in cKO IPCs with respect to control
(Fig. 5P). The ratio between Ts and Tc was not significantly altered (Ts/Tc, ctrl: 0.25;
cKO: 0.24), suggesting that the relative length of the different cell cycle phases was
constant.
Interestingly, the same conclusions were reached by a different approach. We
measured the BrdU labeling index (0.5 hour pulse) in SVZ precursors (Ki67+) at E14.5
(Arnold SJ et al. 2008), finding significant decrease in the number of proliferating Ki67+
cells/100 µm2 area in cKO SVZ with respect to control (ctrl: 19.83 ± 6.04 and cKO: 3.83
± 1.94; n=4, p<0.005; Fig. 7A, B, C), comparable to the reduction in BrdU+ (Fig. 8) and
PH3+ cells in cKO SVZ (Fig. 3J). Consequently, the ratio between the number of Sphase cells (BrdU+) and the total of those proliferating (Ki67+) showed no significant
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difference (ctrl: 0.44 ± 0.02 and cKO: 0.40 ± 0.10; n=4, p=0.34; Fig. 8C). This last set of
data again indicates that Ts/Tc ratio of Arx cKO SVZ precursors is comparable to control.
Consequently, the reduced BrdU incorporation observed in cumulative labeling
experiment of TBR2+ cells can be attributed to a consistent reduction in the proliferation
ability of Arx cKO SVZ progenitors and not to an alteration of their cell cycle length.
Precocious cell cycle exit in Arx cKO cortical progenitors
Since only about half of the pool of IPCs is able to proliferate in Arx cKO cortex,
we predicted precocious cell cycle exit of these cells. Thus, we assessed the fraction of
cells exciting the cell cycle 24 hours after a BrdU pulse (between E13.5 and E14.5).
Cells remaining in the cycle are BrdU+/Ki67+, while those that have stopped cycling
exhibit BrdU labeling only (Chenn A and CA Walsh 2002). At E13.5, an increase of
18% in the cells leaving the cycle is observed in Arx cKO progenitors (leaving fraction in
ctrl: 0.49±0.06; in cKO: 0.58±0.05; n=8 for each, p <0.0005; Fig. 7A’’, B’’, C)
suggesting precocious neurogenesis. Consistent with that, more cells with undiluted
BrdU exist in the Arx cKO when compared to control (arrowheads, Fig. 7A’, B’).
Although it is not possible to distinguish the contribution of RG cells and IPCs to the
fraction of precociously differentiating cells, it is likely that most of those cells are IPCs,
that may exit cell cycle without any round of amplification.
In order to evaluate the effects of IPC reduced proliferation in Arx cKO, we
analyzed GFP expression in E15.5 Arx cKO and relative control mice crossed with
Tbr2::GFP transgenic animals (Fig. 7D, E, D’ E’), where GFP is under the control of the
Tbr2 endogenous regulatory sequences (Kwon GS and AK Hadjantonakis 2007). Due to
the stability of the GFP protein in vivo, GFP fluorescence in Tbr2::GFP mice can be used
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as a lineage tracer of the IPC progeny (Sessa A et al. 2008). We noticed an overall
decrease in GFP+ cells in Arx cKO SVZ and cortical plate with respect to control
consistent with a reduction in the amplification of IPCs in the cKO (GFP+ cells/150 um
area unit, ctrl: SVZ, 55.7±5.13; IZ, 80.00±16.7; CP, 180.33±6.51; total, 316.00±15.39;
cKO: SVZ, 27.70±7.37; IZ, 63.33±26.63; CP, 83.00±2.64; total 181.70± 21.01; n=4
p<0.005 (Fig. 7F).
Given the more pronounced effect of Arx ablation on IPCs than on RGCs, we
sought to assess if Arx is also expressed in IPCs in addition to RGCs (Friocourt G et al.
2006). We performed immunofluorescence for ARX and TBR2 in wild type cortex at
E14.5 and showed that ARX colocalizes with TBR2 in many cells of the VZ/SVZ (Fig.
9).
Arx cKO mice have a reduced number of upper cortical layer neurons with normal
numbers of deeper layer neurons
In order to determine if the reduced proliferation of cortical progenitors has an
effect on cortical lamination, we evaluated molecular markers of cortical layers at
different developmental stages. First, the expression of TBR1 - labeling neurons in
subplate, layer VI and few in layer V (Molyneaux BJ et al. 2007)- was evaluated in
control and Arx cKO mice at E16.5. In Arx cKO the number of TBR1+ cells in layers VVI was slightly decreased with respect to control (TBR1, ctrl layer V-VI= 98.2±6.5; cKO
layer V-VI=82.0±7.8)(Fig. 10A, B). Interestingly, more neurons were found in Arx cKO
subplate, still detectable at this stage (TBR1, ctrl: SP=36.5±4.5; cKO: SP=60.0±3.5)
(arrowheads in Fig. 10A, B).
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A similar difference, although more dramatic, was observed staining for CTIP2,
which labels predominately layer V, but also layer VI neurons (Molyneaux BJ et al.
2007). CTIP2+ cells are already well organized in control layers V-VI, with some
positive cells localized in the subplate, whereas in the Arx cKO they appear less compact
and completely disorganized (arrowheads in Fig. 10C, D). However, the total number of
CTIP2+ cells does not change between Arx cKO and control (CTIP2, ctrl: 166.9±4.2 and
cKO: 155.7±5.7)(Fig. 10U). In order to assess upper layer stratification, we then used P1
and P14 animals. At P1 Arx cKO mice had a decreased number of cells labeled with
SATB2 in layer II/III in the Arx cKO cortices with respect to controls (SATB2 ctrl: layer
II/II= 131.4±18.5 and SATB2 cKO: layer II/III= 96.9±12.6; n=5, p=0.0126)(Fig. 10I, J),
but not in layer IV/V (SATB2 ctrl: layer IV/V=84.0±6.8 and SATB2 cKO: layer IV/V=
77.9±7.6; n=5, p=0.547)(Fig. 10I, J). In addition, the number of cells labeled with
CUX1, a marker of layer II-IV, is also decreased in the Arx cKO cortices (CUX1 ctrl:
layer II-IV= 125.9±7.0 and CUX1 cKO: layer II-IV= 95.9±7.8; n=5, p=0.0327) (Fig. 10IL). However, no significant difference between the Arx cKO and control cortices was
detected for layer V and VI markers (CTIP2 ctrl: total= 97.5±7.5 and CTIP2 cKO: total=
93.2±9.6; n=3, p=0.587; TBR1 ctrl: total= 116.9±4.9 and TBR1 cKO: total= 92.1±14.2;
n=3, p=0.132) (Fig. 10E- H).
At P14, a time in which laminar organization is complete, a decrease in the
number of SATB2 and CUX1 positive cells persisted in layer II/III in the Arx cKO
cortices when compared to control cortices (SATB2 ctrl: layer II/II= 29.5±2.4 layer IV=
41.4±3.8 and SATB2 cKO: layer II/III= 21.2±3.9 layer IV= 24.5±3.0; n=4, p=0.0286;
CUX1 ctrl: layer II-IV= 30.5±2.1 and CUX1 cKO: layer II-IV= 24.9±3.5; n=4,
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p=0.0482)(Fig. 10Q-T). However, similar numbers of CTIP2 positive and TBR1 positive
cells are present in the Arx cKO cortices as compared to control (CTIP2 ctrl: total=
35.5±3.7 and CTIP2 cKO: total= 29.2±1.7, n=3, p=0.272; TBR1 ctrl: total= 32.7±2.1 and
TBR1 cKO: total= 32.5±2.5, n=3, p=0.406)(Fig. 10M-P).
In summary, we find a reduction of upper layers (II-IV) neurons with no change
in deeper layer (V-VI) neurons in Arx cKO mice.
Identification of genes differentially expressed in Arx KO versus wild type cerebral
cortex by transcriptome analysis
To gain insight into the Arx-dependent mechanism responsible for the reduced
proliferation in Arx cKO cortical progenitor cells observed at E14.5, we performed a gene
expression profile analysis. Since all the proliferation defects observed in the Arx cKO
cortices were also detected in Arx KO mouse model (data not shown), we decided to
perform this experiment in Arx KO dorsal telencephalon. E14.5 embryonic stage was
selected for analysis, as the proliferation defect was clearly detectable. Brains were
harvested and the cerebral cortices were carefully dissected and processed for gene
expression profiling (Fig. 11) RNA was separately extracted from the isolated tissues and
used to hybridize Affymetrix microarrays (MOE430v2) containing 45,101 probe sets.
Cortical tissues from Arx KO (n = 5) and control (n = 5) embryos were independently
processed on 10 different gene-chips in order to minimize individual biological
differences. Data sets obtained were then used to identify differentially expressed
transcripts between Arx KO and wild type dorsal telencephali (Fig. 11A-I).
Using a log2 (fold-change ≥ 1 and a FDR ≤ 0.05) linear model, the analysis
revealed that a total of 147 probe sets corresponding to 86 different Entrez Gene
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Identifiers presented significantly different expressions between Arx KO and wild type
cortices (Fig. 11A-I).
Among the full set of identified genes, 3 (DDX3Y, KDM5D and EIF2S3Y) (Fig.
6I) were considered as Arx-independently misregulated. In fact, they correspond to Ylinked expressing units and their upregulation in Arx KO tissues is indicative of a sexbiased harvest of the embryos. This was expected because all Arx KO embryos were
males (Arx−/Y), while wild type embryos displayed an equal probability to be males or
females. The remaining 83 differentially expressed genes were grouped according to the
known or predicted protein function they coded for: transcription factors (Fig. 11A);
receptors (Fig. 11B); intracellular regulatory proteins (Fig. 11C); structural proteins (Fig.
11D); extracellular regulatory proteins (Fig. 11E); extracellular junctions and adhesion
molecules (Fig. 11F); carriers and transporters (Fig. 11G); extracellular matrix proteins
(Fig. 11H).
To ensure the reliability of our analysis, some of the misregulated genes were
selected and analyzed in control and KO tissues using quantitative real-time RT-PCRs
(qPCRs). In this experiment, only RNA extracted from male control embryos was used,
in order to avoid any sex biased gene expression between males and females (Yang F et
al. 2006).
In all cases analyzed, qPCR results confirmed previous gene-array analyses both
for the up-regulated genes RARb, Id1, Id3, Tub6, Olig2, and Cdkn1c as well as the downregulated Pax6 gene (Fig. 11J, all normalized to ß-actin). However, the magnitude of the
changes in expression levels detected by qPCRs was, in some cases, significantly higher
(up to 2.5 fold) when compared to the microarray analyses (RARb, Olig2, Cdkn1c), while,
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in other instances, the results were comparable (Id1, Tub6, Pax6). Interestingly, the
expression of Tbr2 was found decreased in Arx KO compared to control (20% reduction)
in agreement with our immunohistochemistry data, even if the microarray analysis didn’t
show any significant alteration.
Cdkn1c is overexpressed in Arx KO cerebral cortex
Among the genes found to be misexpressed in Arx KO cerebral cortices, we
noticed the upregulation of Cdkn1c. Cdkn1c encodes for CDKN1C (also known as
p57/KIP2), a member of the Cip/Kip family of cyclin dipendent kinase inhibitors (CKIs).
Together with the two other members of this family, CDKN1A and CDKN1B, it exerts a
basilar role in the regulation of cell cycle progression of cortical progenitors at level of
G1/S transition by inhibiting the cyclin/CDK complexes (Sherr CJ and JM Roberts
1999). Recently, Mairet-Coello and colleagues showed that CDKN1C overexpression in
the cerebral cortex elicits precursor cell cycle exit and promotes transition from
proliferation to neuronal differentiation, while opposite effects occur in CDKN1Cdeficient precursors. Indeed, they reported that in mutant mice proliferation of radial
glial cells (RGC) and intermediate precursors (IPC) was increased, expanding both
populations, with greater effect on IPCs (Mairet-Coello G et al. 2012).
As this function is particularly consistent with the phenotype observed in Arx
cKO brains and might underlie the reduction in the cerebral cortex volume, we focused
further analyses on this gene.
In order to ascertain if Cdkn1c misregulation plays a role in Arx KO tissues, we
first assessed its expression by in situ hybridization throughout embryonic development
(E12.5-E18.5) in wild type and Arx KO mouse brain sections (Fig. 12A, B, D, E and Fig.
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13). The expression of Arx was evaluated on adjacent wild type brain sections (Fig. 12C,
F and Fig. 13). At E12.5 Cdkn1c transcript was barely detectable in the SVZ of control
cortices whereas it was significantly overexpressed in both VZ and SVZ of Arx KO (Fig.
12A, B, arrowheads A’, B’). Interestingly, the upregulation of Cdkn1c seemed to follow
a gradient in Arx KO cortices, higher lateral-lower medial (Fig. 12B). Similarly, at
E14.5, Cdkn1c is still expressed in the SVZ in control tissues (Fig. 12D, arrowheads D’)
and overexpression persists in Arx KO cortices (Fig. 12E, arrowheads E’). In contrast to
E12.5, Cdkn1c expression clearly followed a higher medial-lower lateral gradient in both
control and KO cortices (Fig. 12D, E). Beginning on E16.5, Cdkn1c transcript was
additionally detected in cortical plate cells of both control and KO brains and at E18.5 the
level of Cdkn1c up-regulation in Arx KO cortices was significantly diminished, inversely
correlating with the Arx expression pattern at the same developmental stages (Fig. 13).
Similar results were also observed in Arx cKO cortices.
Unexpectedly, although Arx is strongly expressed in the ganglionic eminences, in
particular at E12.5, E14.5 and E16.5 (Fig. 12C, F and Fig. 13), its ablation in Arx KO
mice does not induce Cdkn1c up-regulation in this compartment (Fig. 12B, E and Fig.
13).
In conclusion, our expression analysis of Cdkn1c in wild type and Arx KO
cerebral cortices throughout the neurogenic period, showed that this gene is upregulated
in Arx KO cortical VZ and SVZ, with a pattern that parallels Arx expression in control
tissues. Thus, this correlation raises the possibility that Arx depletion directly promotes
Cdkn1c upregulation in cKO tissues.
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Cdkn1c is a direct transcriptional target of ARX
To determine if Cdkn1c is a direct transcriptional target of ARX, a 5 kb genomic
region upstream to the murine Cdkn1c gene locus was screened for the presence of
putative ARX binding sites. Previous studies identified palindromic sequences
TAAT/ATTA spaced by 3 nucleotides (5’-ATTANNNTAAT-3’) as favored binding sites
for paired homeodomain proteins (Wilson D et al. 1993). Indeed, our search highlighted
the presence of a unique palindromic sequence (5’-ATTAGCATAAT-3’) located
between bases -71/-81 upstream of the Cdkn1c transcription start site (named +1) (Fig.
12G). As binding sites for transcriptional regulators are usually evolutionary conserved,
we performed a multiple alignment of the aforementioned genomic region among
different species, finding a high level of conservation in the ARX putative binding site in
mouse, rat, human and orangutan, except for the 3 spacing nucleotides that were not
conserved in orangutan (Fig. 12G). A genomic region of approximately 500 bp (-549/68) containing the putative ARX binding site and another of about 750 bp (-1490/-720
containing some TA repeats, were separately cloned, upstream to a minimal promoter, in
a construct containing the Luciferase gene and tested for transcriptional reporter activity
(Fig. 12H). The 500 bp (-549/-68)-Luc and 750 bp (-1490/-720)-Luc constructs were
separately co-transfected with control plasmid pCAG-IRESGFP or pCAGArx-IRESGFP
in P19 cells and the effect of ARX expression on the basal transcriptional activity of the
two putative regulative sequences was evaluated. ARX co-transfection reduced the basal
transcriptional activity of the 500 bp regulative region by 30% (fold increase/decrease in
transcriptional activity of pCAG-ArxIRESGFP coinfected with respect to pCAGIRESGFP coinfected: 0.67±0.04; n=3, p<0.005). However, higher reduction was
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detected when the corepressor Tle1 (McKenzie O et al. 2007) was cotransfected in
association with ARX (0.42±0.06, n=3, p<0.005). Surprisingly, ARX and in particular
TLE1 alone are able to repress luciferase transcription; this is due to the fact that both
proteins are already expressed at low levels in P19 cells (data not shown). Conversely,
when pCAG-ArxIRESGFP was cotransfected with the Luciferase construct regulated by
750 bp enhancer, only a slight reduction in the basal transcriptional activity was assessed
(fold increase/decrease in transcriptional activity of pCAG-ArxIRESGFP coinfected with
respect to pCAG-IRESGFP coinfected (transcriptional activity; 0.94± 0.01, n=3,
p<0.05,), even in combination with TLE1 (Fig. 12H). When the binding site 5’ATTAGCATAAT-3’ was mutagenized to 5’-AGGAGCATCCT-3’, no significant
reduction in Luciferase expression was appreciated in cotransfection experiments (Fig.
12H).
These results indicate that ARX exerts a specific transcriptional repression
activity on this 500 bp (-549/-68) genomic region; in order to assess if this repression is
direct or mediated by other factors expressed in P19 cells we performed chromatin
immunoprecipitation experiments. Anti-ARX antibody was used to immunoprecipitate
chromatin isolated from E14.5 telencephali; then, PCR amplification reactions, with
primers designed to span the 500 bp (-549/-68) region upstream to Cdkn1c gene, allowed
us to evaluate an enrichment of that region in the ARX immunoprecipitated chromatin
with respect to IgG only and anti-GFP immunoprecipitated chromatin (Fig. 12I).
Amplifications with primers spanning Ebf3 regulatory region were also performed and
used as a positive control, as Ebf3 was previously showed to be a direct target of ARX in
the ventral pallium (Fulp et al., 2008). We found enrichment of the Cdkn1c (and Ebf3)
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regulatory regions when pulled down with an anti-ARX antibody but not with the antiGFP or no antibody controls. No enrichment in ARX immunoprecipitated chromatin
samples was detected amplifying for Cdkn1a and Cdkn1b regulative regions (Fig. 12I), as
expected by the absence of any alteration of the two gene transcripts in Arx KO cortices.
Taken together, these results suggest that ARX is a direct repressor of Cdkn1c
transcription and it likely exerts this role by direct interaction with the palindromic
binding site 5’-ATTAGCATAAT-3’ located in the 500 bp enhancer region.

Discussion
Loss of ARX/Arx in both humans and mice results in a reduced size of the cerebral
hemispheres. In this study, by crossing Arxfl/y mice with Emx1Cre mice, we have
confirmed that the reduced brain size is largely if not completely due to the loss of Arx in
cortical progenitor cells. Indeed, in E14.5 Arx cKO we observed a reduction in the
number of cortical progenitor cells, both PAX6+ and TBR2+, that might be the result of
the precocious RG progenitor differentiation observed at E12.5 in Arx cKO.
However, this cannot be the only underlying mechanism. In fact, also the
proliferation rate of cortical progenitor cells is affected in Arx cKO and our data suggest
that the IPC pool is more affected than the RGC compartment: almost all S-phase
progenitors in E14.5 Arx cKO cortices are PAX6+ cells and only rarely TBR2+.
Consistent with this, basal mitoses are dramatically reduced. Interestingly, the
determination of the growth fraction at E13.5 allowed us to understand that, whereas all
the cKO RG progenitors were able to proliferate at that stage, only 45% of TBR2+ cells
in Arx cKO could enter cell cycle (versus the 75% of the control). These observations
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support the hypothesis that the drastic effect on the IPC proliferation is not only due to a
premature differentiation among VZ progenitors but essentially to a direct effect of ARX
ablation on IPCs. In line with this, we found ARX expression in many TBR2+ cells of
the VZ/SVZ.
This reduction of cortical progenitor cells led to an alteration of the cortical
layering: a significant loss of cells from the superficial layers of Arx cKO cerebral cortex
with relative preservation of the deeper layers. Our observations in this genetic model
complement those found after an acute reduction of Arx through the in utero
electroporation of an Arx shRNA in mid gestation where an increased number of
progenitors exiting the cell cycle and prematurely adopting the neuronal fate were found
(Friocourt G et al. 2008).
We also performed a gene expression profile analysis in wild type and Arx KO
cerebral cortices that identified 83 misregulated genes. Interestingly, this analysis found
very little overlap with the results of the same analysis that we previously performed in
the ganglionic eminences (Fulp CT et al. 2008; Colasante G et al. 2009). These data
reinforce the assertion that ARX exerts region specific roles in the ventral telencephalon
and in the cerebral cortex through the activation/repression of different transcriptional
programs (Nasrallah MP et al. 2012). In agreement with the reduction of GABAergic
interneurons migrating to the cerebral cortex in Arx KO brains (Kitamura K et al. 2002;
Colombo E et al. 2007), markers of specific interneuron subclasses (NPY, Somatostatin
and also LHX6) were downregulated in KOs. However, among the several misregulated
genes, we focused our attention on Cdkn1c, as we considered it the most interesting Arx
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putative target, whose up-regulation could account for the phenotype observed in Arx
cKO cortices (Mairet-Coello G et al. 2012).
Our characterization of the Cdkn1c expression pattern during normal
corticogenesis found Cdkn1c to be expressed in the SVZ in the first phases of
neurogenesis (E12.5-E14.5). At later stages it is also detected in the cortical plate (CP).
Conversely, in Arx cKO, it is strongly upregulated in the VZ and SVZ starting at E12.5.
The expression of Cdkn1c during corticogenesis has been debated for a long time. While
early reports indicated that Cdkn1c mRNA is localized in the VZ, SVZ, and CP of
embryonic rat cortex (van Lookeren Campagne M and R Gill 1998), CDKN1C protein
has been localized in the CP, with faint expression in the IZ and no signal in the VZ/SVZ
(Nguyen L et al. 2006; Itoh Y et al. 2007). A few recent studies have helped clarify this
issue (Nguyen L et al. 2006; Tury A et al. 2011; Mairet-Coello G et al. 2012; Tury A et
al. 2012). Using an antibody against CDKN1C, they found it is expressed mainly in
differentiating postmitotic neurons, but also it colocalizes with TBR2+ cells in SVZ and
with some PAX6+ in VZ. These data are fully consistent with our data on Cdkn1c
expression obtained by in situ hybridizations.
Recently Tury et al. (2011) showed that CDKN1C overexpression in E14.5–15.5
rat embryos elicits precursor cell cycle exit and promotes transition from proliferation to
neuronal differentiation. Comparing the neurogenic and astrogliogenic effects of
CDKN1B and CDKN1C, they discovered that CDKN1C overexpression promotes more
neuronal differentiation than CDKN1B (Tury A et al. 2011). The specific neurogenic
effect of CDKN1C is particularly interesting in relation to its expression in IPCs, which,
distinct from RGCs, generate only neurons. However, they do not clearly analyze the
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specific effect of CDKN1C overexpression on the two cortical progenitor cell
populations. In their follow-up work, Mairet-Coello et al. (2012), analyze the phenotype
of Cdkn1c mutant mice, finding that proliferation of both RGCs and IPCs is increased,
expanding both precursors with greater impact on IPCs.
In this context, our report is the first to describe the effect of CDKN1C
overexpression on cortical progenitor cell proliferation, integrating the analysis
previously performed. Interestingly, our data also support the hypothesis that CDKN1C
is more relevant for IPC than RGC cell cycle exit, although CDKN1C is overexpressed in
both cortical VZ and SVZ, the most dramatic effect is observed on IPC and not on RGC
proliferation.
We propose a model for the Arx-dependent control of cortical progenitor cell
proliferation (Fig. 14). Arx expression in the VZ and partially in the SVZ is able to
repress Cdkn1c premature expression, allowing proliferation of RGC cells and expansion
of IPCs. When Arx is normally downregulated, the consequent up-regulation of
CDKN1C in the SVZ favors IPC cell cycle exit. In contrast, in Arx KO cortex, CDKN1C
expression is high in the VZ resulting in a mild proliferation effect on RGC cells. More
dramatic is the impact on TBR2+ IPCs; these progenitors have already such a high level
of CDKN1C that directly exit the cell cycle without significant cell division.
Certainly, the presence of other alterations or compensatory mechanisms cannot
be excluded in Arx cKO cortices. For example, the microarray analysis highlighted the
up-regulation of Id1 and Id2 genes in Arx KO cortices. It is known that their targeted
disruption in mice results in premature withdrawal of progenitor cells from the cell cycle
and expression of neural-specific differentiation markers (Lyden D et al. 1999). Thus, it
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is likely that their overexpression in Arx cKO cortices might compensate for the Cdkn1c
up-regulation, mitigating the full phenotypic expression. Among the compensative
mechanisms, we could also consider the slight acceleration of cell cycle duration in IPCs
observed in Arx cKO.
We also demonstrated that Cdkn1c is a direct transcriptional target of ARX. The
genomic region 5’ to the murine Cdkn1c gene locus was screened for the presence of the
ARX putative binding site and a unique palindromic sequence (5’-ATTAGCATAAT-3’)
was located a few bases upstream of the Cdkn1c transcription start site. Luciferase
assays allowed us to demonstrate that ARX, together with the corepressor TLE1, is able
to repress transcription through binding at the identified 500bp enhancer region.
Furthermore, chromatin immunoprecipation revealed that ARX directly binds in this 500
bp Cdkn1c enhancer region.
Surprisingly, the ARX binding site that we identified in this study is different
from the one described in our previous work (Fulp CT et al. 2008). In that work we
analyzed the transcription factor binding sites (TFBSs) significantly enriched in the
regulatory regions of genes whose expression increased within Arx KO subpallium, we
identified the sequence TAATTA. In a recent study using the ChIP-chip methodology in
ARX transfected N2a cells almost 50% of Arx immunoprecipitated sequences N2a cells
were unequivocally enriched for TAATTA binding site in comparison to controls (Quille
ML et al. 2011). In this same study, only 20% of the genes ARX immunoprecipitated in
E15.5 mouse embryonic brains were found to have this binding site; furthermore, any
other motif enriched in ARX-bound sequences by comparison to control sequences, could
not be identified (Quille ML et al. 2011). These results suggest that whereas
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overexpressed ARX seems to be recruited primarily to TAATTA, in more physiological
conditions such as in embryonic brain, ARX is recruited to other less common motifs or
needs other factors for DNA binding. Based on these data, the ATTAGCATAAT site we
identified might be one of the in vivo binding sites to which ARX is recruited.
Surprisingly, the ChIP on chip analysis performed by Quillé and colleagues revealed that
ARX binds the Cdkn1a (p21/Cip1) promoter but not Cdkn1c, however this might be due
to limitations of the ChIP-chip technique. Indeed, ChIP-seq experiments might allow
further delineation of ARX direct transcriptional target genes.
In summary, our data indicate ARX plays a unique role in the progenitor cells of
the cerebral cortex when compared to its role in the ventral forebrain. By genetically
eliminating Arx from pallial progenitor cells we find a reduction in the number of RGC
due to a premature exit from the cell cycle and significant skipping of the IPC
amplification stage of corticogenesis. This defect results in the predicted deficit in upper
later neurons of the cerebral cortex. We further elucidated the pathogenesis of this defect
by identifying the cell cycle regulator CDKN1C as a downstream target of ARX. Our
study extends our understanding of the aberrant molecular network responsible for the
reduced proliferation observed in Arx cKO forebrains; indeed, this is a critical point for
understanding the pathogenic mechanisms underlying these devastating neurologic
disorders and in devising genetic or cellular therapeutic strategies to ameliorate Arx
mutation induced pathological phenotypes.

48

Figure 1: Reduction in cerebral cortex and olfactory bulb dimensions is observed in Arx
cKO brains. (A, B) At E11.5 ARX expression is lost in the cortical VZ of Arx cKO brains when
compared to control brains. (C-H) At E14.5 the Arx cKO brains exhibit a reduced size of the
cerebral hemispheres and the olfactory bulbs (C, D). Nissl stained coronal sections (E, F) and
corresponding high magnification of the cerebral cortex (G, H) highlight a diminution in the
cortical thickness in the Arx cKO brains when compared to controls. (I-N) Morphological
analysis of postnatal (P30) control and Arx cKO brains confirms the previous observations:
cortical vesicles and olfactory bulbs are under developed, whereas the cerebellum and the brain
stem do not appear to be affected (I, J); Nissl stained coronal sections reveal an overall reduction
in the telencephalic structures in Arx cKO brains, involving the cerebral cortex and hippocampus
(K, L). Magnifications of cortical areas show an increased nuclear density in the deeper layers
(IV-VI) of Arx cKO compared to controls (M, N). (O) Quantifications of relative cortical volume
(rv) at E14.5 and P30 of Arx cKO brains compared to controls. Error bars correspond to S.D. (P,
Q) The corpus callosum is absent in Arx cKO brains. Cx, cortex; Hyp, hippocampus, Pyr,
pyriform cortex; cc; corpus callosum.
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Figure 2: At E12.5 Arx cKO cortices display a slight decrease in cortical progenitor
proliferation and increase in differentiation. Immunohistochemistry for ßIII -tubulin (TUBB3)
in E12.5 control (A, A’) and Arx cKO cortices (B, B’) highlights an increase in the number of
differentiated young neurons in Arx cKO cortex compared to control, corresponding to a slight
decrease in the number of KI67+ proliferative progenitor cells (C-D’). (E-F’) Merge of ßIII tubulin and KI67 staining in control and Arx cKO cortex. (F) Quantification of the percentage ßIII
-tubulin + and KI67+ cells at E12.5 in control and Arx cKO cortex.
50

Figure 3: Proliferation rate of radial glia cells and intermediate progenitors is reduced in
Arx cKO cerebral cortex. E14.5 coronal sections from control (left) and Arx cKO cortices
(right) are directly compared. Ki67 stained sections (A, B) and corresponding higher
magnification (E, F) reveal an overall reduction of proliferating cells in Arx cKO cortex
compared to wild type; (C) quantifications of Ki67+ cells in a 150 µm bin extending from the
ventricular to pial surface: control 259±21.8 and cKO 202.5±16.3; n=6 for each, p value < 0.001.
(D, E, F, G, H, I) PAX6, TBR2, BrdU and PH3 immunolabelings performed on wild type and Arx
cKO sections from embryos treated with 1 hour pulse of BrdU. (D’-E’’’) Reduction in the
number and in the signal intensity of PAX6+ cells (D’, E’) and in the number of BrdU+ (D’’, E’’)
in Arx cKO cortices compared to the control. (F’-G’’’) A reduction in the number of TBR2+
cells (arrowheads, F’, G’) and a decrease in TBR2+/BrdU+ double positive cells (arrowheads,
D’’’, E’’’) in Arx cKO cortices compared to the control are shown (H’-I’) Reduction of PH3+
cells is observed in the Arx cKO cerebral cortex, greater in the basal rather then in the apical
region. (J) Quantifications of total PAX6+ and TBR2+ cells, dual-labeled PAX6+/BrdU+ and
TBR2+/BrdU+ double positive cells and PH3+ in E14.5 wild type and Arx cKO cortices are
shown.
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Figure 4: Arx cKO cerebral cortex shows no increase in apoptosis with respect to control
during embryonic development. Immunohistochemistry for Caspase3 (red) in control and Arx
cKO cortices at E13.5 (A, B), E15.5 (C, D) and E17.5 (E, F). Comparable numbers of Caspase3+
cells can be observed in both control and Arx cKO coronal sections.
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Figure 5: Cell cycle kinetic is not affected in both Arx cKO VZ and SVZ progenitors, but
IPC growth fraction is severely reduced (A-J’’) Cortical fields of BrdU and TBR2 labelings
performed on control and Arx cKO cortices at 5 (0.5, 3.5, 6.5, 9.5 and 12.5 hours) of the 6 time
points of the BrdU cumulative labeling experiment are shown. (K-M) Double labeling for TBR2
and KI67 and quantification of KI67+TBR2+ normalized on total TBR2+ cells reveals a severe
reduction of the IPC proliferating fraction in Arx cKO with respect to control. (N-O) Labeling
indices (L.I.) for both control and cKO RG and IPC progenitor (calculated as the ratio between
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TBR2+ BrdU+ cells on the total of TBR2+ and normalized on the IPC growth fraction in the
latter case), are plotted against correspondent BrdU labeling times and the interpolating lines are
drawn. (P) Evaluation of cell cycle duration (Tc) and S-phase duration (Ts) are reported.
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Figure 6: Arx cKO cortices display fewer IP proliferating cells also later on during
development. Immunohistochemistry for TBR2 (red) and KI67 (green) in control (A) and Arx
cKO (B) cortices at E17.5 revealing a decrease in TBR2+ cells in the cKO cortex with respect to
control, with very little percentage of them, still proliferating (TBR2+ Ki67+). (C) Quantification
of the percentage of proliferating IPC cells (TBR2+ Ki67+) on the total IPC cells (TBR2+) in
both the control and cKO cortex (ctrl: 15.57±2.50; cKO: 7.69±0.26, n=4 each, p=0.0458, t test)
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Figure 7: Increased cell cycle exit affects Arx cKO progenitors and the progeny of TBR2+
cells is reduced. (A,B) E14.5 control and Arx cKO cortical sections were double labeled for Ki67
and BrdU, following BrdU injection at E13.5. (C) Quantification of the proportion of cells
leaving the cycle (leaving fraction: BrdU+Ki67-/tot BrdU+ cells). (D, E) E15.5 coronal sections
and relative higher magnifications (D’, E’) of control and Arx cKO in the transgenic background
Tbr2::GFP analyzed for GFP expression reveal a reduction in number and intensity of GFP+ cells
in Arx cKO SVZ , subplate (SP) and cortical plate (CP) (F).
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Figure 8: Cell cycle length is normal in Arx cKO SVZ precursors while (A-B’’) E14.5 wild
type and Arx cKO cortical sections were double labeled for KI67 and BrdU following a 1-hour
BrdU pulse. (C) Quantifications of KI67+ cells in control and cKO SVZ and of Brdu+ Ki67+
double positive cells on the total of Ki67+.
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Figure 9: ARX is expressed in TBR2+ intermediate precursor cells. (A) E14.5 coronal
sections of cortex and relative higher magnifications (A’, A’’, A’’’) of control brains labeled for
TBR2 (A’) and ARX (A’’). (A’’’) Higher magnification showing the presence of ARX and TBR2
co-stained cells in both cortical VZ and SVZ.
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Figure 10: Cortical layering is altered in Arx cKO brains. Immunohistochemistry for
molecular markers identifying deeper cortical layers at E16.5 and both deeper and upper cortical
layers at P1 and P14, in control and Arx cKO cortices (A-T). (A, B) TBR1+ cells are slightly
decreased in layer V-VI neurons and increased in subplate in E16.5 Arx cKO cortices with respect
to the controls; (C, D) CTIP2 immunolabeling shows the same alterations observed with TBR1
although more prominantly. (E, F) At P1, similar numbers of TBR1+ cells in Arx cKO cortices
with respect to control are detected as well as a similar number of CTIP2+ cells in both layer V
and VI (G, H). (I, J) SATB2 is decreased in upper layer neurons (II, III) in the Arx cKO cortices
with respect to the controls; (K, L) Similarly, staining for CUX1 (layers II-IV) shows a
diminution of upper cortical layer neurons in Arx cKO cortices with respect to controls. (M-P) At
P14, there are still similar numbers of TBR1+ and CTIP2+ cells in the Arx cKO cortices when
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compared to controls but still a decrease in SATB2+ cells in layers II/III (Q, R). Similarly, there
are also still fewer CUX1+ cells in the Arx cKO cortices (S, T). (U) Quantifications of TBR1+
and CTIP2+ cells in layer VI and V and of SATB2+ and CUX1+ at E16.5, P1 and P14 in both
control and Arx cKO cortices. TBR1+ and CTIP2+ cells at P14. Cells positive for each molecular
marker were counted 25% of the cortex in P1 and in a 200 µm bin in P14, both from the
ventricular to the pial surface in both control and Arx cKO cortices.
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Figure 11: Outline of the gene expression profile analysis and hierarchical clustering of the
transcripts found differentially expressed between control and Arx KO dorsal
telencephalon. (A-I) The 86 genes found differentially expressed between control and Arx KO
cerebral cortices were grouped according to the protein function they codify for, in: (A)
transcription factors; (B) receptors; (C) intracellular regulatory proteins; (D) structural proteins;
(E) extracellular matrix proteins; (F) extracellular regulatory proteins; (G) junctions and adhesion
molecules; (H) carriers and transporters; (I) Y linked genes. (J) 7 genes found misregulated by
microarray analysis were selected for quantitative real-time RT-PCRs (qPCRs) validation.
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Figure 12: The cyclin dependent kinase inhibitor (CKi) Cdkn1c is ectopically expressed in
Arx KO cortical VZ and SVZ and it is a direct transcriptional target of ARX. In situ
hybridizations for Cdkn1c on telencephalic coronal sections at different embryonic stages (E12.5E14.5) of control (left) and Arx KO (right) brain tissues; in situ hybridizations for Arx on control
coronal sections at the corresponding developmental stages are also showed. (A-C) At E12.5
Cdkn1c transcript is detected in the neo-formed SVZ in control brains (arrowheads, A’);
differently, in Arx KO, it is significantly upregulated in both VZ and SVZ (arrowheads, B’),
where Arx is normally expressed at this stage (C). Similarly, Cdkn1c is found upregulated in Arx
KO VZ and SVZ at E14.5 (arrowheads, E’) whereas in the relative control sections it is still
barely detected in the SVZ (arrowheads, D’). (G) A 5 kb genomic region upstream to the murine
Cdkn1c gene locus was screened for the presence of paired homeodomain binding sites: a
palyndromic sequence 5’-ATTAGCATAAT-3’, highly conserved in mouse, rat, human and
orangutan, was found between -71/-81 bp before the Cdkn1c transcription start site (+1). (H) A ∼
500 bp (-549/-68) genomic region containing the putative ARX binding site, a ∼ 750 bp (-1490/720) containing some TA rich repeats and the same 500 bp (-549/-68) genomic region with the
binding site mutagenized 5’-AGGAGCATCCT-3’ were separately cloned in a construct
containing the Luciferase gene and tested in transcriptional activity assays in P19 cells. When the
500 bp(-549/-68)-Luc construct is cotransfected with pCAG-ArxIRESGFP a reduction in
Luciferase expression compared control plasmid pCAG-IRESGFP cotransfection was appreciable
(0.67±0.04; n=3, p<0.005,); similar reduction was observed when the corepressor TLE1 was
cotransfected (0.60±0.07, n=3); finally, higher reduction was detected when both ARX and TLE1
were cotransfected (0.42±0.06, n=3). Differently, ARX cotransfected with the 750 bp(-1490/720)-Luc induced only a slight reduction in the basal transcriptional activity (0.94± 0.01, n=3,
p<0.05,), even in combination with TLE1. When the binding site 5’-ATTAGCATAAT-3’ was
mutagenized in 5’-AGGAGCATCCT-3’, no significant reduction in Luciferase expression was
appreciable in cotransfection experiments. (I) Immunoprecipitation of E14.5 telencephalic
chromatin with anti-ARX, anti-GFP and IgG only. Primers spanning the 500 bp(-549/-68)
genomic region upstream to the Cdkn1c, and Ebf3, Cdkn1b and Cdkn1a regulative regions were
used for PCR analysis of the immunoprecipitated DNA. Enrichment of the PCR products in antiARX immunoprecipitated chromatin sample compared to the anti-GFP and IgG only samples was
evaluated
62

Figure 13: Expression of the cyclin dependent kinase inhibitor (CKi) Cdkn1c in Arx KO
cortical VZ and SVZ, at later stages of development. In situ hybridizations for Cdkn1c on
telencephalic coronal sections at late embryonic stages (E16.5-E18.5) of control (left) and Arx
KO (right) brain tissues; in situ hybridizations for Arx on control coronal sections at the
corresponding developmental stages are also showed. At E16.5, in control sections, Cdkn1c
transcript is still detected in the SVZ (arrowheads, A’) and it starts to accumulate also in the
cortical plate cells (arrows, A’); in the corresponding Arx KO tissues, upregulation in the VZ
(arrows, B, B’) is still evident as well as the expression in the cortical plate (arrowheads, B, B’).
Consistently, Arx transcript is still detected at E16.5 in control section VZ (C). At E18.5, only a
slight up-regulation of Cdkn1c is still detectable in Arx KO VZ (E, E’) in agreement with a
reduced residual expression of Arx at this stage (F).
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Figure 14: Schematization of the molecular mechanism through which ARX controls
cortical progenitor expansion. ARX expression in the cortical VZ/SVZ normally represses
CDKN1C expression allowing progenitor cell proliferation and expansion. Loss of Arx in the
VZ/SVZ causes precocious CDKN1C upregulation in the cortical progenitors cells, which results
in a mild decrease in proliferation of RGCs and a significant loss of IPC proliferation, with
consequent cell cycle exit. This ultimately results in a loss of upper layer neurons in the adult
cortex.
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CHAPTER 3: Conditional loss of Arx from the developing dorsal telencephalon
results in behavioral phenotypes resembling mild human ARX mutations
Introduction
Aristaless-Related Homeobox gene (ARX) is one of the more commonly mutated
genes causing X-linked intellectual disability (XLID) (Lin CH et al. 2009; Shoubridge C
et al. 2010). Over 44 distinct mutations have been found resulting in a spectrum of
phenotypes (Shoubridge C et al. 2010). Mutations that lead to a deletion or truncation
along with those that reside in the homeodomain cause primarily brain malformation
phenotypes such as X-linked lissencephaly associated with ambiguous genitalia (XLAG),
hydranencephaly, and Proud syndrome (agenesis of the corpus callosum) (Bonneau D et
al. 1992). Point mutations outside the homeodomain, in non-conserved amino acids of
the homeodomain, missense mutations, and poly-alanine track expansion mutations lead
to various neurological phenotypes that are mainly characterized by intellectual
disability, but frequently also include epilepsy (typically infantile spasms), autism, or
dystonia but typically have no structural brain defects (Lafaucheur L et al. 1992; Turner
G et al. 2002). The only phenotype consistently observed in patients with all ARX
mutations is intellectual disability.
Mice with a germline loss of Arx have a thin disorganized cortex, malformed
thalamus, major white matter tract defects (corpus callosum and thalamo-cortical), and
mislocalization and loss of interneurons in the cortex and striatum (Kitamura K et al.
2002). Unfortunately these mice die shortly after birth precluding behavioral or EEG
phenotyping. In the developing telencephalon Arx is expressed in pallial progenitor cells
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located in the ventricular zone (VZ) and in subpallial sub-ventricular zone (SVZ) cells,
which generate interneurons that populate the cortex, striatum, and hippocampus. The
selective removal of Arx from interneurons results in no brain malformations, but similar
to the knockout mouse they have fewer interneurons in the cerebral cortex and
hippocampus (Marsh E et al. 2009). They also have a severe epilepsy phenotype with
features overlapping those observed in some patients with ARX mutations (Marsh E et al.
2009). Hence, it appears that perturbation of the developing interneurons is sufficient to
produce an epileptic phenotype that recapitulates the seizures found in patients with ARX
mutations. Selective removal of Arx from the pallial progenitor cells using an shRNA
against Arx at e13.5 causes the progenitors cells to prematurely exit the cell cycle and the
VZ, however because this was just a partial knock down it is unclear what affect this has
on later development of the cortex (Friocourt G et al. 2008).
In contrast to mice with a germline loss of Arx (Kitamura K et al. 2002), mice
deficient for Arx in cortical interneurons (Arx-/Y Dlx5/6Cre mice) have a normal cortical
thickness, indicating an interneuron independent function of Arx on cortical thickness
(Marsh E et al. 2009). To examine the role of Arx in cortical development, we mated
ArxF/X mice to Emx1Cre mice, which selectively deletes Arx from the dorsal telencephalon
(pallium). These mice have a thin cerebral cortex, similar to the Arx knockout, and are
predominantly missing superficial layer neurons, sparing deeper layer neurons, due to a
loss of proliferating intermediate progenitor cells (Colasante G et al. 2013). Since loss of
Arx in interneurons appears to cause the epilepsy phenotype we sought to determine
which characteristics of the human ARX patient phenotype might be explained by loss of
Arx in cortical progenitor cells. Thus, we performed a detailed behavioral and anatomic
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analysis of the Arx-/Y Emx1Cre mice to determine the functional consequences of Arx loss
in cortical progenitors and whether this loss may model specific phenotypic aspects of
human ARX patients.

Materials and Methods:
Mice
Arx conditional mutant mice (ArxF/X) (Fulp CT et al. 2008) were maintained on a
C57Bl/6 background. To inactivate Arx in the dorsal telencephalon specifically during
development ArxF/X heterozygous female mice were crossed with homozygous male
Emx1Cre/Cre animals also on a C57Bl/6 background (Jax Mouse Strain 005628).
Genotyping to distinguish wild type, floxed, and cre positive alleles was performed as
described (Jin XL et al. 2000; Fulp CT et al. 2008). Mice were maintained at the
Children’s Hospital of Philadelphia animal facility on a 12:12 hours light-dark cycle
(lights on 0600-1800 hours) and ad libitum Lab Diet mouse food 5LG4. All experiments
were approved by the Institutional Animal Care and Use Committee of the Children’s
Hospital of Philadelphia.
EEG Recordings and Analysis
All electrophysiologic studies were conducted as previously described (Marsh E
et al. 2009). Adult animals at least 3 months old were used for all EEG recordings.
Briefly, under isoflorane anesthesia, 4 electrodes were stereotaxically implanted (3
cortical-left and right frontal, right parietal and a hippocampal depth) using the
67

coordinates in our previous publication (Marsh E et al. 2009). The animals recovered in
their home cage for 48 hours prior to recordings and then were transferred to the
recording cage and recorded with a Triangle Biosystems preamplifer and a Stellate EEG
recording system (Natus Technologies) for 48 to 96 hours.
The EEG and video were reviewed manually for the presence of seizures.
Background EEG was quantified as previously published (Marsh E et al. 2009). Briefly
ten 10-second segments of awake and asleep EEG were randomly selected, but checked
for artifact and behavioral state. The awake state was defined as the period when the
mouse was moving with hippocampal theta present. In contrast, when the animal was
still, head down, and delta dominated the EEG it was considered asleep. A Fast Fourier
Transform (FFT) was calculated for each segment (MATLAB 2010b, Mathworks, Inc.,
Natick, MA) and the resultant spectrums were quantified by calculating the power in
selected bandwidths (Delta 0.1-3.5Hz, Theta 3.5-8.5Hz, Alpha 8.5-13Hz, Beta 13-25Hz,
and Gamma 25-100Hz) and dividing by total FFT power. The percent power in each bin
was averaged across genotype and compared using a Student’s t-test in Excel (version
12.2.7, Mircosoft). To correct for the 10 comparisons, a difference was considered
significant if the p value was less than 0.005 (the Bonferoni correction). Eight mutant
mice and six wild type mice were recorded for 3 days each, but only 4 wild type and 4
mutant mice were analyzed using the FFT.
Behavioral Studies
Behavioral testing was conducted during the light phase between 1000 and 1800
hours (h), starting at 8 weeks of age and each individual paradigm was separated by at
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least 2 days. Mice were handled for 5 minutes each day for 3 days prior to the beginning
of testing. Six cohorts of mice were used for behavior testing. Each cohort consisted of
at least two different litters of mice. See Chapter 3; Table 1 for a list of the tasks each
cohort of mice performed. The numbers of mice tested for each task are listed below.
Only male mice were tested and all cohorts were a mix of mutant mice (ArxF/Y
Emx1Cre/Cre) and wild type littermates (ArxX/Y Emx1Cre/Cre). Cleaning wipes (PDI SaniCloth Plus germicidal disposable cloth) were used to clean equipment between mice.
With the exception of grip strength and rota-rod, all paradigms were video recorded and
automatically scored using ANY-maze software (Stoelting Co., Wood Dale, IL).
Grip Strength
The grip strength of the mice was tested using a grip strength meter (080312-3
Columbus Instruments, Columbus, Ohio). Each mouse was tested in 6 consecutive trials;
the first 3 were for forelimbs, and then 3 more for hindlimbs. The value from each trial
was recorded and the forelimb and hindlimb trials were each averaged and taken as the
result for that mouse. (Golub MS and SL Germann 2001; Fowler SC et al. 2002; Munn E
et al. 2011) The results for all mutant mice and their wild type littermates were compared
using a two-tailed unpaired Student’s t-test in Excel; WT=13 and Mut=14.
Rota-rod
Mice were tested on a rota-rod from Ugo Basile (Model 47600, Comerio, Italy).
The mice were tested in groups, 5 at a time for 6 minute trials with 5 trials per day for 4
days. The rota-rod was used in acceleration mode, accelerating every 6 seconds up to 60
rpm. The latency until falling for each mouse was recorded. Between trials the mice
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were placed back into their home cages. (Crawley JN 2007; Miwa JM and A Walz 2012;
Heyser CJ et al. 2013) Each day, the trials were averaged and the genotypes were
compared across the four days using a repeated measure ANOVA in Prism (version 5.0,
GraphPad, San Diego, CA); WT=13 and Mut=14.
Home Cage Activity
Mice were placed in plastic EEG recording boxes (Marsh E et al. 2009) with their
normal bedding and food and were allowed to acclimate for 2 days before being video
recorded for 3 days. The video was analyzed using an in-house program written in
MATLAB that detects movement by subtracting pixels between each video. The pixel
counts were averaged over the 3 days of recordings for each genotype. The genotypes
were compared using a Student’s t-test in Excel; WT=8 and Mut=8.
Open Field
A 53 x 53 cm plastic box with 22cm high walls and no top was used in a well-lit
room (450 lumens/meter2). The mice were placed in the center of the box and allowed to
roam freely in the box for 15 minutes. The mice were video recorded and scored using
ANY-maze software. ANY-maze scored a mouse to be in the periphery if it was within
13cm of the wall of the box. Otherwise they were considered to be in the center of the
box. (Crawley JN 2007; Buschert J et al. 2013; Han Q et al. 2013) The ratio of time in
the center to time in the periphery was calculated and averaged. The distance traveled
during the test and the number of crossings between the center of the box and the
periphery were also calculated and averaged using the ANY-maze software. Genotypes
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were compared using a two-tailed unpaired Student’s t-test in Microsoft Excel version
12.2.7; WT=20 and Mut=21.
Light/Dark Box
A 55 x 28cm plastic box with 22cm tall walls and divided in half was used. Both
sides of the box were accessible by a 7.5 x 7.5cm door in the middle. One half of the box
was clear with no top and the other half was black plastic with a covered top. The mice
were placed in the box on the light side and allowed to roam freely for 15 minutes. The
tests were video recorded and scored using ANY-maze software. (Bale TL et al. 2000;
Bourin M and M Hascoet 2003; Crawley JN 2007) The ratio of time in the light side of
the box to time in the dark side was calculated and averaged for each genotype and
compared using a two-tailed unpaired Student’s t-test in Excel. The linear distance the
animal traveled during the test and the number of crossings between the two sides was
also calculated and analyzed the same way; WT=17 and Mut=14.
Marble Burying
A clear plastic cage, 32 x 43cm, with 19cm high walls was filled with 5cm deep
corncob bedding evenly covering the bottom. Twenty-four marbles, spaced 6cm apart,
were placed evenly on top of the bedding. The mice were placed in the box and allowed
to roam freely and bury marbles for 30 minutes. After 30 minutes, the number of marbles
buried at least two thirds of the marble’s depth with bedding was recorded. (Deacon RM
2006; Krass M et al. 2010; Chioca LR et al. 2013) The tests were video recorded and
scored for distance traveled using ANY-maze software. The number of marbles buried,
71

and the distance traveled was calculated and averaged for each genotype and compared
using a two-tailed unpaired Student’s t-test in Excel; WT=8 and Mut=8.
Morris Water Maze
The Morris water maze consists of a 128cm diameter round plastic tub filled with
21°C water to within 15cm of the top of the tub and a 0.5 cm above a square clear plastic
platform. White tempera paint was mixed into the water until it was opaque enough that
the edge of the platform could not be seen from the side. Spatial cues were placed around
the tub and were not moved for the duration of the experiments. The mice were tested
using 4 trials per day for 5 days. The mice were placed in the tank in a different location
for each trial and the order of locations was changed each day (see (Vorhees CV and MT
Williams 2006) and Chapter 3;Table 1). In each trial mice were allowed to swim for up
to 60 seconds before being led to the platform. Once on the platform, the mice were
allowed 10 seconds of observation time. The latency to find the platform (up to 60
seconds) for each trial was recorded and averaged for each day. The genotypes were
compared using a repeated measures ANOVA in Prism. On the 6th day a probe trial was
performed to test the memory of the location of the platform. In this trial, the platform
was removed and the mice swam around the tub, searching for the missing platform for
60 seconds. The time spent in the quadrant of the tub where the platform had been and in
the opposite quadrant was recorded and compared using an unpaired Students t-test. A
reversal test was then performed for 5 days following the probe trial. During this test, the
platform was placed on the opposite side of the tub and the mice were re-trained, with the
same protocol of 4 trials a day for 5 days. A reversal probe trial was performed on the 6th
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day in the same fashion as the first probe trial. (Crawley JN 2007; Harris L et al. 2013)
The same statistical analysis was performed for the reversal trials as for the learning test;
WT=20 and Mut=21.
Contextual Fear Conditioning
Each mouse was placed in a modular test chamber (Model ENV-307W, Med
Associates, Inc., Georgia, VT) and allowed to explore the box for 2 ½ minutes before a 2
second foot shock of 1.12 mA was given with a SA shock scrambler (ENV-4145), a
digital timer (SG-592), and a 1 Amp power supply (SG-501 Med Asoociates, Inc.,
Georgia, VT). The mouse was then left in the box for another 28 seconds before being
removed to its home cage. Twenty-four hours later the mouse was placed in the same
modular test chamber and was video recorded for 5 minutes using ANY-Maze software,
which quantified time spent not moving (freezing). (Wood MA et al. 2005; Crawley JN
2007; Cole JT et al. 2010) The amount of time spent freezing was compared across
genotypes using an unpaired Student’s t-test; WT=17 and Mut=14.
Social Choice Test
A social choice apparatus was constructed from the description by Sankoorikal
(Sankoorikal GM et al. 2006). The bottom of the chamber was covered with bedding and
that bedding was changed for each mouse tested. The protocol used to test the mice was
the same as the one used in Fairless et al. 2008. Briefly, the mice were first acclimated to
the chamber for 10 minutes. Then a novel object was added to one tube and a
gonadectomized male mouse to the other tube and the behavior of the test mouse was
recorded for 5 minutes. The tubes were then removed and the behavior of the test mouse
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while interacting with the gonadectomized mouse was observed for another 5 minutes,
unless the mouse was aggressive in which case both mice were removed immediately.
The test mouse was then returned to its home cage. A single novel object was used for
all tests and was cleaned, along with the apparatus before each test. Each
gonadectomized male was used only once per day. The side of the chamber that had the
mouse or the object was alternated between tests. (Nadler JJ et al. 2004; Crawley JN
2007) The tests were video recorded and scored using ANY-maze software. The time
spent in the social section, the center, and the non-social section was compared using a
Two-way ANOVA in Prism. The ratio of the amount of time spent within 3cm of the
tube with the mouse (sniffing social tube) verses the time spent within 3cm of the tube
with the object (sniffing object tube) was calculated and averaged for each genotype and
compared using a Student’s t-test in Excel. The number of entries to either the social
section of the box (mouse) or the non-social section of the box (object) was also
calculated and compared across genotypes; WT=15 and Mut=18.
Buried Food Test of Olfaction
For 2 days prior to the test each mouse was given a Froot Loop (Kellogg's® Froot
Loops® Cereal) in its cage and the next day the cage was checked to make sure they ate
the Froot Loop. Mice were then deprived of food for 24 hours. The next day a Froot
Loop was buried in 1.5 cm deep bedding in a clean normal mouse cage with nothing else
but the top of the cage. A mouse was placed in the cage and the time to dig up the piece
of food documented, up to 10 minutes. (Moy SS et al. 2004; Crawley JN 2007; Yang M
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and JN Crawley 2009) The average time for each genotype was compared using an
unpaired Student’s t-test; WT=8 and Mut=8.
In Situ Hybridization
P21 and P30 mice were perfused transcardially with phosphate buffered saline
(PBS) followed by 4% paraformaldehyde (PFA). The brains were removed and post
fixed in 4% PFA overnight at 4°C. Fixed brains were cryoprotected in 30% sucrose and
coronally sectioned at 10um. All slides were baked at 65°C for 20 minutes, post-fixed in
4% PFA for 10 min, washed in phosphate buffered saline with 0.1% Tween-20 (PBT).
The slides were then acetylated for 10 min in 0.1 M TEA (1.86% triethanolamine, 0.4%
10N NaOH, 0.5% acetic anhydride, and water) and washed in PBT. The Glutamate
decarboxylase 67 (GAD67) probe (courtesy of Dr. N. Tillakaratne (Erlander MG et al.
1991)) was added at 1:1000 in pre-warmed hybe solution (50% formamide, 5x SSC, 2%
blocking reagent (Roche, Mannheim, Germany; 11096176001), 0.1% Triton, 0.15
CHAPS, 1mg/ml tRNA from yeast, 5mM EDTA, 50ug/ml heparin) and incubated
overnight at 65°C. Slides were washed with 5x SSC, then incubated with 1xSSC/ 50%
formamide 30 minutes at 65°C, then TNE (10mM Tris pH 7.5, 500nM NaCl, 1mM
EDTA, and water) for 10 minutes at 37°C, then RNaseA for 30 min at 37°C and washed
with TNE and then at 65°C with 2x SSC and 0.2x SSC for 20 min, each. Then the slides
were incubated in MABT pH 7.5 (100mM maleic acid, 150mM NaCl, 0.1%tween-20,
and water) and blocked in MABT with 2% blocking reagent (Roche) and 20% goat serum
for 1 hour at room temperature. Slides were incubated overnight at 4°C in MABT with
2% blocking reagent and 5% goat serum and anti-DIG antibody 1:2500 (Roche,
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11093274910). The slides were then washed with MABT and then NTM. The slides
were then incubated with 1ml BM Purple (Roche, 11442074001) in the dark, overnight at
room temperature. The slides were then washed with NTM and PBS, fixed in PFA,
dehydrated to 100% ethanol, and mounted with Permount (SP15-500, Fisher Scientific).
Immunohistochemistry
P21 mice were processed as described in in-situ section above. The brains were
cryoprotected in 30% sucrose and cryosectioned coronally at 10um or 16um. All slides
were baked at 37°C for 30 minutes. Two antibodies, Somatostatin (SST; Rabbit 3387-1,
Epitomics, Burlingame, CA; 1:50) and Parvalbumin (Parv; Mouse MAB1572, Millipore,
Billerica, CA; 1:100) were used to assess for changes in interneuron subtypes. For the
Sst antibody, antigen retrieval was performed in citric acid-based Antigen Unmasking
Solution (H-3300, Vector Laboratories, Burlingame, CA) autoclaved at 105°C for 20
minutes. For the Parv antibody the MOM blocking reagent (FMK-2201, Vector
Laboratories) was used for 30 minutes followed by blocking for 30 minutes with 10%
normal goat serum (Sigma) in TBST (TBS with 0.5% triton) all at room temperature.
After antigen retrieval, SST sections were blocked for 30 minutes at room temperature
with 0.5% normal goat serum (Sigma) in TBST. Anti Parv primary was diluted in 1%
normal goat serum in TBST and Anti-Sst was diluted in 0.5% normal goat serum in
TBST and incubated on slides overnight at 4°C. The secondary antibodies used were a
biotinylated goat anti-mouse (BA-9200, Vector Laboratories, 1:300) and biotinylated
goat anti-rabbit (BA-1000, Vector Laboratories, 1:300), diluted in TBST and placed on
slides for 30 minutes at room temperature. The biotinylated secondary antibodies were
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subsequently incubated with ABC kit mix (PK-6100, Vector Laboratories) in PBS for 30
minutes and then ImmPACT DAB for 2 minutes (SK-4105, Vector Laboratories). Slides
were counterstained with hematoxylin, dehydrated, and mounted with Permount. Stained
sections were viewed on a Leica DM6000B equipped with a Leica DFC360FX digital
camera. 10X images were taken of the entire cortex for each section and then stitched
together using Fiji version ImageJ 1.45b.
Nissl Staining
Cresyl Violet acetate (C5042, Sigma-Aldrich) (0.1g) was mixed with 100 mL
distilled water. To each 10ml of Cresyl Violet acetate solution 50µL of 15% glacial
acetic acid was added and the solution was filtered to make Nissl stain. Cryosections
were covered in Nissl stain for 10 minutes and then washed 2 times with distilled water.
The sections were destained by dipping them once in acid alcohol (50% ethanol/50%
distilled water with 0.1% HCl). Slides were mounted with Flouromount-G (0100-01,
SouthernBiotech) and imaged the same as the immunohistochemistry sections.
Cell Counting
For the GAD67 counts a 1mm area of the cortex from the pial surface to the white
matter directly above the hippocampus (2mm posterior to Bregma) and 2mm from the
medial edge of the cortex was counted. For the basolateral amygdala counts all of the
Nissl stained neurons in the basolateral amygdala (2.1mm posterior to Bregma) were
counted. Cell counts were averaged for each genotype and compared using an unpaired
Student’s t-test.
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MRI
Adult mice brains were processed as described above, and then post-fixed in 4%
PFA for 2 weeks. Prior to MRI the samples were transferred to a PBS 1X solution
containing 0.2mM Gd-DTPA (Gadopentetic acid)(J140 Omniscan GE Healthcare). At
the time of scanning the samples were removed from the PBS/Gd-DTPA solution, rinsed
with pure PBS and introduced in a short 11 mm glass tube containing Fomblin (317993
Sigma-Aldrich) to provide a susceptibility match and a black background for the images.
Bubbles were carefully removed by tapping gently on the tube. An inverted Pasteur
pipette was inserted on top of the brain to maintain the tissue immersed in the Fomblin.
MRI was performed at 9.4T in a vertical bore magnet (Avance III Bruker-Biospin Inc)
using the micro 2.5 self-shielded gradients (2.5G/cm/A) and a 15 mm RF coil. The
image acquisition and reconstruction was performed with the Paravision software 5.1
(Bruker Biospin Inc.). The temperature of the sample was maintained at 37C. Diffusion
tensor images and T2 weighted 3D images of the brain tissue were obtained sequentially
with the DTIEpi 30 directions and the 3D turboRARE Bruker protocols respectively.
The following conditions were used: for the DTI, field of view (FOV) 20 x 12.8 x 10
mm, data size (SI) 128x80x64, which results in a resolution of 160 m3, number of
averages (NEX) 2, repetition time (TR) 1250 ms, echo spacing (Te) 26 ms, 8 segments,
bandwidth 300kHz, diffusion gradients 3ms, diffusion gradient separation 7.53ms, 30
directions, 5 A0 images and a B value of 1500 s.mm2. The duration of the acquisition
was 12h 26 min. For the 3D rare the parameters were FOV 19.2 x 12.8 x 9.6 mm, SI
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256x176x128, giving a resolution of 75 m3, 5 NEX, TR 1500 ms, Te 13 ms, echo train 8
which results in an average echo time of 39 ms and a 5h long experiment. To analyze the
T2 weight images for volume data on specific brain regions. We used a registrationbased segmentation method to extract various structures in T2-weight MR images
of mouse brains. A mouse brain atlas with accompanying labels of structures of interest
was registered to the target image. We adapted the mouse atlas from Johns Hopkins
University, which is available to the public (http://cmrm.med.jhmi.edu/). Registration
was aligned followed by non-rigid diffeomorphic warping using Advanced
Normalization Tools (ANTs), which is an open-source software freely available online.
The labels were also transformed to the target space by the same warping and thus
completed the segmentation.

Results:
Arx-/Y Emx1Cre mutant mice have normal numbers of interneurons
We previously found that Arx-/Y Emx1Cre mice have reduced numbers of upper
cortical layer neurons with relative sparing of neurons in the deeper layers (Colasante G
et al. 2013). Arx expression was preserved in the developing ventral telencephalon and in
the interneurons migrating from the ganglionic eminence to the cortex (Colasante G et al.
2013). Several studies have found that changes in the development of cortical excitatory
neurons can affect interneuron migration into the cortex (Sessa A et al. 2010; Lodato S et
al. 2011). Therefore, to confirm that cortical interneurons were not adversely affected by
the loss of upper layer neurons we first assessed the total number of interneurons using a
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GAD67 in situ hybridization probe on sections from brains of P21 Arx-/Y Emx1Cre
(mutant) mice and their wild type littermates (ArxX/Y Emx1Cre). Similar numbers of
interneurons were found in the mutant brains when compared to wild type brains
(Chapter 3;Fig. 1B,C; WT= 137.3±5.84 and Mut=124±2.65; n=3 for each; p=0.1359).
We next sought to exclude the possibility that while the total number of
interneurons was unchanged, subtypes of interneurons were disproportionately
represented (Azim E et al. 2009). Labeling for two interneuron subtypes, parvalbumin
and somatostatin, which together mark 50-70% of all cortical interneurons (Xu X et al.
2010; Rudy B et al. 2011), revealed both types to be similarly represented (parvalbumin
WT=50±5 and Mut=53±2; n=3 for each; p=0.6575; somatostatin WT=37±7.23 and
Mut=29±2.89; n=3 for each; p=0.3897)(Chapter 3;Fig. 1C). Thus, both the total number
and representative subtypes of interneurons were unaltered by the loss of Arx from the
dorsal telencephalon.
Arx-/Y Emx1Cre mice do not have seizures
Patients and mice with ARX/Arx mutations have seizures as a principle feature.
The conditional loss of Arx from developing interneurons in the ventral telencephalon
(Arx-/Y Dlx5/6Cre) results in a severe seizure phenotype (Marsh E et al. 2009).
Furthermore, mice with a polyalanine track expansion mutation or with a point mutation
in the homeobox also have seizures (Kitamura K et al. 2009; Price MG et al. 2009). To
determine if the loss of Arx from the cortical projection neuron progenitor pools (Arx-/Y
Emx1Cre mice) is also associated with seizures, video-EEGs were recorded for up to 96
hours following our previously published protocol (Marsh E et al. 2009). Review of up
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to 96 hours of EEG and video recordings from 8 mutant mice and 6 control animals
revealed no seizures in the either the mutant or control mice. However, there were
differences that were observed in the EEG (Chapter 3;Fig. 1A). Qualitatively, the EEG
appeared to be slower in the Arx-/Y Emx1Cre mice than the wild type mice (Chapter 3;Fig.
1A). To confirm our visual interpretation, we performed a Fast Fourier Transforms
(FFTs) on randomly selected awake and sleep EEG segments in the cortex from 6 control
and 4 mutant mice. An increase in Delta (Awake: WT=23.50±4.34 and Mut=29.69±4.85
p=0.0036, Sleep: WT=22.19±3.84 and Mut=31.77±3.84 p=2.3x10-8) and decrease in
Alpha or Beta (Awake; Alpha: WT=9.28±0.77 and Mut=11.06±1.53 p=0.0017; Sleep;
Beta: WT=16.88±1.00 and Mut=14.20±1.24 p=9.2x10-7) and Gamma (Awake:
WT=32.08±3.92 and Mut=24.83±2.89 p=9.1x10-6; Sleep: WT=30.96±3.11 and
Mut=24.16±2.46 p=4.7x10-6; WT n=6 and Mut n=4) power was present during both sleep
and awake states (Chapter 3;Fig. 1B). Similar, results were seen in the FFTs for the
hippocampal recordings (Chapter 3;Fig2A,B). Interestingly, this change in EEG
frequency content is the opposite from the Arx-/Y Dlx5/6Cre mice, which had an increase in
faster (Beta and Gamma) activity (Marsh E et al. 2009).
Arx-/Y Emx1Cre mutant mice have normal spatial learning and memory
An invariant feature among males with an ARX mutation is a severe intellectual
disability (Shoubridge C et al. 2010). To investigate whether the Arx-/Y Emx1Cre mice had
intellectual disabilities we performed several learning and memory tests. Prior to
performing these tasks, physical strength and coordination defects were evaluated and
excluded. Grip strength and rota-rod testing revealed no differences between the Arx-/Y
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Emx1Cre mice and their wild type littermates (Chapter 3;Fig. 3A,B Grip strength:
Forelimb: WT= 0.042±0.0033, n=13 and Mut=0.052±0.0053, n=12; p=0.1030; Hindlimb:
WT= 0.079±0.0055, n=13 and Mut=0.082±0.0044, n=12; p=0.3447; Rota-rod: WT n=13
and Mut n=12; p=0.0801). Thus, no motor deficits were uncovered suggesting the
mutant mice should have normal physical capabilities.
Once a motor abnormality was excluded, the Morris water maze test was
performed to assess spatial learning and memory. The mice were first trained with spatial
cues around the tank and the platform hidden. There was no difference in learning the
task as both mutant mice and wild type littermates located the platform in similar times
each day of training (Chapter 3;Fig. 4A; WT n=20 and Mut n=21; p=0.0669). Next,
memory for the platform location was probed by recording the time spent in the original
quadrant of the platform after the platform was removed (Chapter 3;Fig. 4B). Again,
there was no difference found between the mutant and wild type mice (Chapter 3;Fig. 4B:
Time (secs) in platform quadrant: WT=22.8±1.47 and Mut=25.6±1.97; p=0.271; Time in
opposite quadrant: WT=9.61±1.07, n=20 and Mut=7.7±1.28, n=21; p=0.256). Finally,
reversal learning and memory testing, which is a more sensitive indicator to changes in
cortical function, was tested by relocating the platform to the opposite side of the tank.
No differences were noted in this measure of cortically-mediated learning (Chapter 3;Fig.
4C; WT n=20 and Mut n=21; p=0.1545) or memory (Chapter 3;Fig. 4D: Time (secs) in
platform quadrant: WT=19.5±0.87 and Mut=19.9±1.33; p=0.762; Time in opposite
quadrant: WT= 11.7±0.85, n=20 and Mut=11.7±1.02, n=21; p=0.997). Thus, by the
highly-standardized and accepted Morris water maze paradigm the Arx-/Y Emx1Cre mice
exhibit normal spatial learning, memory, and reversal learning.
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Arx-/Y Emx1Cre mutant mice have normal fear memory, but are hyperactive
In some mutant mouse strains hippocampal based spatial learning and memory
can be normal despite alterations in other forms of learning such as fear conditioning
learning because the hippocampus is not as involved in this type of learning (Angelo M et
al. 2003; d'Isa R et al. 2011; Albarran-Zeckler RG et al. 2012). To test whether the Arx-/Y
Emx1Cre mutant mice had a learning and memory deficit independent of spatial learning,
we tested the animals in a conditioned fear-learning task. The mutant mice spent
significantly less time freezing than their wild type littermates did both during the
training session and during the testing session (Chapter 3;Fig. 4E: percentage of time
spent freezing training: WT=10.5±1.06, n=17 and Mut=5.57±0.82, n=14; p=0.00099;
percentage of time spent freezing testing: WT=52.1±3.65, n=17 and Mut=34.4±4.99,
n=14; p=0.0086). This suggests that the mutant mice are hyperactive; a finding
confirmed by the longer distances travelled by the mutant mice than their wild type
littermates during the testing session (Chapter 3;Figure 5A: distance traveled:
WT=2.43±0.42, n=17 and Mut=4.00±0.49, n=14; p=0.0217). The ratio of the percentage
of time spent freezing during the training session verses the testing session indicated that
the mutant mice learn the contextual fear conditioning just as well as their wild type
littermates (Chapter 3;Figure 5B: ratio of percentage of time spent freezing traing/testing:
WT=5.36±0.43, n=17 and Mut=6.80±1.31, n=14; p=0.3097).
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Arx-/Y Emx1Cre mutant mice are anxiolytic, more exploratory, and more active than
wild type mice.
Surprisingly, no learning deficit was uncovered but there was a suggestion of a
more active state, therefore we further examined the mutants exploratory and anxiety
behaviors. To evaluate the anxiety level of the Arx-/Y Emx1Cre mutant mice open field and
light/dark box tests were used. For the open field test, mice with a higher ratio of the
time spent in the center to time spent in the periphery of the chamber are considered to
have a low anxiety-like or anxiolytic phenotype. Mutant mice appeared anxiolytic as
they spent significantly more time in the center of the box compared to their wild type
littermates (Chapter 3;Fig 6A: WT= 0.170±0.019, n=20 and Mut=0.229±0.020, n=21;
p=0.0405). For the light/dark box, testing the ratio of time spent on the light side of the
box compared to the time on the dark side of the box was used as a measure of anxiety.
Again, the mutant mice spent significantly more time on the light side when compared to
their wild type littermates suggesting a reduced anxiety-like phenotype (Chapter 3;Fig
6C: WT= 0.891±0.118, n=17 and Mut=1.61±0.202, n=14; p=0.00204).
Both the open field and light/dark box tests can also be used to quantify the
activity level of mutant mice. In both, the mutant mice travelled further than their wild
type littermates indicating a higher activity level in the mutant mice (Chapter 3;Fig.
6B,D: Open field: WT= 65.9±3.02 cm, n=20 and Mut=77.6±3.79 cm, n=21; p=0.0201;
Light/dark box: WT= 12.2±0.867 cm, n=17 and Mut=20.2±1.13 cm, n=14; p=0.000007).
Similarly, the mutant mice crossed between the light and dark side of the box and
between the center and the periphery of the open field, which also indicates higher
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activity (Chapter 3;Fig. 7A,B: Open field: WT=117±6, n=20 and Mut=158±8, n=21;
p=0.0000863; Light/dark box: WT= 28±1, n=17 and Mut=40±4, n=14; p=0.00143).
However, the mutant mice displayed normal activity levels in home cage recordings so
they appear to be more active only in novel environments (Chapter 3;Fig 3C:
WT=13.75±1.73 Δ pixels/frame, n=8 and Mut=12.59±1.84, n=8; p=0.5191).
Since our data suggests that the Arx-/Y Emx1Cre mice are both anxiolytic and more
active in both the open field and the light/dark box tests, we wanted to determine whether
the increased activity was confounding our anxiety test results. Therefore, we performed
a marble burying test, another anxiety test, but one in which less activity constitutes
lower anxiety (Thomas A et al. 2009). We found that the mutant mice buried significantly
fewer marbles then the wild type animals (Chapter 3;Fig. 6E: WT= 6.13±1.25, n=8 and
Mut=0±0, n=8; p=0.00759) yet they were still hyperactive based on distance traveled in
the novel cage (Chapter 3;Fig. 6F: WT= 85.34±2.10cm, n=8 and Mut=93.42±5.94cm,
n=8; p=0.2322), similar to the open field and light dark box. This indicates that although
still hyperactive in a novel environment, they were less anxious than their wild type
littermates. Together, the data suggests that the anxiety and hyperactivity phenotypes are
separable and the Arx-/Y Emx1Cre mice are both less anxious and hyperactive when
compared to their wild type littermates.
Arx-/Y Emx1Cre mutant mice have social deficits
One of the core symptoms of autism is abnormal social interactions (Crawley JN
2007; Silverman JL et al. 2010). To test for the mice for “social” deficits we performed
the social choice task (Crawley JN 2007; Silverman JL et al. 2010). In the social choice
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task the test mouse is given a choice between a novel object and novel mouse. As mice
are normally social animals they should typically spend more time exploring a novel
mouse then a novel object. Therefore, we compared the time spent in the area of the
novel mouse (social), the time spent in the center, and the time in the section with the
novel object (nonsocial) (Sankoorikal GM et al. 2006; Fairless AH et al. 2008). The Arx/Y

Emx1Cre mutant mice appear to have a socialization deficit as they spent significantly

less time in the social section of the box (Chapter 3;Fig. 8A; Time spent in social section:
WT= 142.07±8.54, n=15 and Mut=111.37±4.28, n=18; p<0.001). In addition, the mutant
mice entered the social section of the box significantly fewer times as compared to the
wild type mice (Chapter 3;Fig. 8B; WT= 2.97±0.50, n=15 and Mut=1.44±0.14, n=18;
p=0.00952). Similarly mutant mice spent significantly less time sniffing around the
novel mouse verse the novel object than their wild type littermates did (Chapter 3;Fig.
8B; WT= 4.53±0.80, n=15 and Mut=2.15±0.18, n=18; p=0.01379).
The olfactory ability of the mice was tested using the buried food test in order to
rule out the possibility that reduced olfactory ability was confounding the social choice
test. Both the mutant mice and their wild type littermates found the buried Froot Loop in
similar amounts of time showing that the mutants have normal olfactory skills (Chapter
3;Fig 8C; WT=143.38±34.86 and Mut=242.13±79.60, n=8 for each; p=0.2834).
Arx-/Y Emx1Cre mutant mice have smaller cerebral cortices, amygdalas, and white
matter tracts
In addition to the neurocognitive and behavioral deficits patients with various
ARX mutations exhibit, structural defects such as lissencephaly, agenesis of the corpus
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callosum and microcephaly are present in many patients (Suri M 2005; Friocourt G et al.
2006; Gecz J et al. 2006). In an effort to begin linking the structural defects with the
neurocognitive deficits we examined regional size variation and connectivity. Using
structural MRI in fixed Arx-/Y Emx1Cre and wild type mouse brains the volume of various
brain structures was calculated (Chapter 3;Fig. 9). As observed in Nissl stained sections
the cerebral cortical volume was significantly smaller in the mutant mouse (Colasante G
et al. 2013)(Chapter 3;Fig. 9A,C,E). The MRIs also revealed the corpus callosum and
anterior commissure to be significantly reduced in volume, as is also found in patients
with various ARX mutations (Proud VK et al. 1992; Bonneau D et al. 2002; Marsh E et al.
2009)(Chapter 3;Fig. 9A,C,D,E). However, analysis of the MRIs also reveled that the
amygdala volume was significantly smaller in the mutant mice (Chapter 3;Fig. 9E). It is
possible that there are changes to the amygdala in the Arx-/Y Emx1Cre mice since both Arx
and Emx1 are expressed in the amygdala (Puelles L et al. 2000; Medina L et al. 2004;
Poirier K et al. 2004; Remedios R et al. 2007). To confirm this finding, we counted
neurons in the basolateral amygdala in Nissl stained sections and found that the number
of neurons was reduced (Chapter 3;Fig. 10C; WT=1118±124 and Mut=891±152, n=3 for
each; p=0.01952). Interestingly, the behavioral phenotypes of decreased anxiety and loss
of fear memory have been hypothesized to represent amygdala dysfunction (Phillips RG
and JE LeDoux 1992; Grillon C et al. 1996; Tottenham N et al. 2010; Schienle A et al.
2011). Combining the MRI volume changes with the loss of cells in the basolateral
amygdala suggest that amygdala dysfunction could explain at least part of the Arx-/Y
Emx1Cre behavioral phenotype. Over all, the MRI data are consistent with the hypothesis
that the Arx-/Y Emx1Cre mutant mice have a long-range connectivity defect. Unexpectedly
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the thalamus was also significantly smaller in the mutant mice even though the Cre is not
expressed in the diencephalon, suggesting a possible corticothalamic connectivity defect
(Chapter 3;Fig. 9E) that could contribute to the abnormal behaviors found in these mice.

Discussion:
Loss of Arx in dorsal progenitors resulted in structural, functional and behavioral
deficits in the Arx-/Y Emx1Cre mice. Specifically, we demonstrated that disruption of both
local superficial cortical connections, long-range connections between hemispheres and
within limbic regions results in a hyperactive and anxiolytic mouse that socializes poorly.
Of note, these behaviors all occur in the absence of ongoing epilepsy as a confounding
variable. By comparing the deficits in the Arx-/Y Emx1Cre mice to those of the previous
Arx mutant mice and the clinical phenotype of ARX patients we can begin to shed some
insight into the possible function of different cortical regions, connections, and the lack
of a role for seizures in generating the behaviors found in the Arx/ARX mice and patients.
The complete Arx knockout mouse created by the Kitamura lab had a thin cortex
due to decreased cortical progenitor proliferation during development (Kitamura K et al.
2002). Loss of Arx expression in the cortical VZ at e13.5 causes cortical progenitor cells
to exit the cell cycle and the VZ prematurely (Friocourt G et al. 2008). Our lab recently
determined that Arx-/Y Emx1Cre mice have thinner and smaller cortices and are specifically
missing superficial layer neurons and not deeper layer neurons (Colasante G et al. 2013).
A loss of proliferative intermediate progenitor cells was found to be the cause of the
thinner cortex (Colasante G et al. 2013). Unlike most other Arx mutant mice, these mice
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do not die at a young age, likely because they do not develop seizures (Chapter 3;Fig.
1A) and have intact olfaction allowing for normal feeding behaviors. Consistent with a
lack of seizures, Arx-/Y Emx1Cre mice have normal numbers of interneurons in their
cortices (Chapter 3;Fig. 1B). Therefore, we wanted to examine the behavioral phenotype
of these mice to determine the impact on cognitive functioning of isolated loss of upper
layer neurons, without the complicating factors of interneuron loss and seizures as found
in all other Arx mutant mice models.
Intellectual disability is the common feature of all human ARX mutations. To
determine what aspects of the human condition the Arx-/Y Emx1Cre mice recapitulate, we
tested learning and memory. Somewhat surprisingly, the Morris water maze test did not
reveal any abnormalities in spatial learning and memory and the contextual fear
conditioning test did not reveal any abnormalities in fear learning and memory (Chapter
3;Fig. 4A-E). This contrasts to the Arx(GCG)7/Y mice and the ArxPL/Y mice which showed
impaired spatial learning in the win-shift task of the eight-arm radial maze and impaired
passive avoidance learning (Kitamura K et al. 2009). The Arx(GCG)7/Y mice also showed
impaired procedural learning in the win-stay task (Kitamura K et al. 2009). Another
Arx(GCG)10+7 mouse also showed impaired learning of the fear conditioning task (Price
MG et al. 2009). These data indicate that the learning deficits seen in the other Arx
mutant mice might be due to, either individually or in combination, the of loss of
interneurons in the cortex and the hippocampus or the seizure activity they exhibit.
The Arx-/Y Emx1Cre mice registered less anxiety-like behavior and increased
exploration as evidenced by their spending significantly more time in the center of the
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open field and in the light part of the light/dark box than their wild type littermates
(Chapter 3;Fig. 6A and B). In addition, the mice were hyperactive, having travelled a
further distance during both tests (Chapter 3;Fig. 6B and D). These findings are similar
to the Arx(GCG)10+7 mice that also were reported to have a low anxiety and hyperactivity
phenotype (Price MG et al. 2009). However, other Arx mutant mice (Arx(GCG)7/Y and
ArxPL/Y mice) were more anxious in the same tests (Kitamura K et al. 2009). Based upon
these varying results, no conclusions can be made regarding the relationship of these
behavioral phenotypes to alterations in excitatory or inhibitory interneurons of the cortex
or seizure burden. These changes in anxiety in Arx mutant mice could also be explained
by changes in the amygdala, which was not investigated in any of the other Arx mutant
mice, but do exist in the Arx-/Y Emx1Cre mutant mouse.
Autistic features, including social deficits and stereotypies, have been described in
patients with ARX mutations (Turner G et al. 2002; Shoubridge C et al. 2010). The Arx-/Y
Emx1Cre mice appear to have social deficits in the social choice test (Chapter 3;Fig. 8A).
This is similar to the Arx(GCG)10+7 mice for which there was a reported deficit in the tube
test for social dominance (Price MG et al. 2009). This suggests that the autistic
phenotypes of these mice could be due either to changes in the excitatory neurons of the
cortex, amygdala or the connections between the two.
Arx-/Y Emx1Cre mice have decreased cerebral cortical and amygdala volumes,
which can be correlated with the behavioral phenotypes of decreased anxiety-like
behavior, hyperactivity, and social deficits. The cortical defect described in these mice
(Colasante G et al. 2013) is one explanation for these behavioral findings. Another
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possible rationale for these behavioral deficits is defects in the amygdala structure as
indicated by the volume and neuron number changes. The combined or separate roles of
these two brain structures in mediating these behavioral functions requires further
investigation. The white matter tract abnormalities (including the corpus callosum, the
anterior commissure, and possibly the cortico-thalamic tract) suggest a loss of long-range
connectivity between different brain regions in these mutant mice. Agenesis of the
corpus callosum was reported in the Arx knockout mice, but not in the Arx(GCG)10+7,
Arx(GCG)7/Y, ArxPL/Y, or ArxPR/Y mice (Kitamura K et al. 2002; Kitamura K et al. 2009;
Price MG et al. 2009). It has also been documented in some ARX patients with XLAG or
Proud syndrome and heterozygous females from families with these syndromes (Proud
VK et al. 1992; Bonneau D et al. 2002; Marsh E et al. 2009). In contrast, corpus
callosum agenesis has been seen in both severely affected males and in unaffected carrier
females making it unlikely for corpus callosal defects alone to be the primary mechanism
of the behavioral deficits seen in mice and patients.
The differences in the frequency composition of the EEG between the Arx-/Y
Emx1Cre and wild type mice were reminiscent of the slow background and increase in
Delta activity that is present in most children with a diffuse encephalopathy, including
children with ARX mutations. Though nonspecific, a slow EEG background suggests
diffuse brain dysfunction as might be expected in a cortical layer defect (Pedley TA
1980). Interestingly, the composition of the EEG in the Arx-/Y Emx1Cre and Arx-/Y
Dlx5/6Cre are different, with the interneuron specific mouse (Arx-/Y Dlx5/6Cre) gaining
faster frequency activity and the excitatory neuron specific mouse (Arx-/Y Emx1Cre)
gaining slower activity (Marsh E et al. 2009). This difference supports the notion that
91

interneurons and subcortical structures are necessary for the generation of Theta and
Gamma oscillations, and local cortical networks are not (Bragin A et al. 1995;
Whittington MA et al. 2011).
The absence of seizures in the Arx-/Y Emx1Cre mice provided a unique opportunity
to separate out the basic structural and cellular deficits from the resulting seizures on a
variety of behavioral phenotypes. Neurologists question the ultimate role of seizures in
generating the cognitive deficits in their patients (Shinnar S and WA Hauser 2002;
Hamiwka LD and EC Wirrell 2009; Hermann BP et al. 2009). These studies demonstrate
that for ARX related disorders, alterations in anxiety, hyperactivity, social deficits, and
repetitive behaviors could be unrelated to the epilepsy. Indeed, the absence of epilepsy,
altered anxiety, hyperactivity, and social deficits observed in these Arx mutant mice are
reminiscent of patients with mild ARX phenotypes. Other phenotypes, like the small
amygdala, have not been studied in this relatively small patient population. It remains
possible that a more thorough brain imaging and behavioral analysis of these patients
might reveal even more similarities between the Arx-/Y Emx1Cre mice and patients with
ARX mutations.
Overall, the Arx-/Y Emx1Cre mouse line, with the other conditional and mutant Arx
mice that have been generated offer an opportunity to dissect apart a complex circuit to
look for local circuit or regional connections that are necessary or sufficient for the
generation of complex behaviors. We acknowledge at the onset that this is a difficult
endeavor as any one change in a developing system alters the others and that both
cognitive and social behaviors are complex tasks that involve the function of networks,
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not just cortical regions and layers. With those caveats in mind, our findings suggest an
important role for superficial cortical regions and the amygdala, in the generation of a
hyperactive, anxiolytic, anti-social phenotype.
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Table 1: Cohorts of mice used in behavior experiments and order of behavior tests.
Cohort
1
2
3
4
5
6

Number of Mice
WT=3 Mut=4
WT=10 Mut=8
WT=13 Mut=9
WT=4 Mut=5
WT=11 Mut=13
WT=8 Mut=8

Order of Behavior Tests
Grip Strength, Rota-rod, Open Field, Water Maze
Grip Strength, Rota-rod, Open Field, Water Maze
Light/Dark Box, Open Field, Water Maze, Fear Conditioning
Light/Dark Box, Buried Food, Social Choice, Fear Conditioning
Buried Food, Social Choice
Buried Food
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Figure 1: Arx-/Y Emx1-Cre mice do not have seizures and have normal interneuron numbers.
A) Samples of cortex recordings for Arx-/Y Emx1-Cre mice (Mut) and their control wild type
littermates (ArxX/Y Emx1-Cre), which showed no seizure activity. B) Quantifications of EEGs of
the cortex by Fast Fourier Transform (FFT) on both Awake and Sleep segments for wild type and
mutant mice (Awake; Delta: WT=23.50±4.34 and Mut=29.69±4.85 p=0.0036, Theta:
WT=19.61±2.60 and Mut=18.32±1.63 p=0.1894, Alpha: WT=9.28±0.77 and Mut=11.06±1.53
p=0.0017, Beta: WT=15.54±1.46 and Mut=16.11±1.68 p=0.4199, Gamma: WT=32.08±3.92 and
Mut=24.83±2.89 p=9.1x10-6; Sleep; Delta: WT=22.19±3.84 and Mut=31.77±3.84 p=2.3x10-8,
Theta: WT=19.32±1.42 and Mut=19.55±1.41 p=0.7178, Alpha: WT=10.65±0.83 and
Mut=10.32±1.13 p=0.4597, Beta: WT=16.88±1.00 and Mut=14.20±1.24 p=9.2x10-7, Gamma:
WT=30.96±3.11 and Mut=24.16±2.46 p=4.7x10-7; WT n=6 and Mut n=4). C) Quantifications of
interneurons in a 1mm bin of cortex from ventricular to pial surface from in situ hybridizations of
GAD67 and immunofluorescence staining of parvalbumin and somatostatin on adult brain
sections showing no difference in total number of interneurons (GAD67; WT= 137.3±5.84 and
Mut=24±2.65; n=3 for each; p=0.1359) and no change in the number of interneurons of two
subtypes (Parv; WT=50±5 and Mut=53±2; n=3 for each; p=0.6575; and SST; WT=37±7.23 and
Mut=29±2.89; n=3 for each; p=0.3897). Error bars correspond to S.E. D) GAD67 in situ
hybridizations on cryosections of P21 brains of wild type (ArxX/Y Emx1-Cre) and mutant (ArxF/Y
Emx1-Cre) brains. Section of the cortex just above the hippocampus from pial surface (top) to
white matter (bottom). Error bars are S.E.
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Figure 2: Arx-/Y Emx1Cre mice have increased lower frequencies in their EEGs and decreased
higher frequencies. A and B) Quantifications of EEGs of the hippocampus by Fast Fourier
Transform (FFT) on both Awake (A) and Sleep (B) segments for wild type and mutant mice
(Awake; Delta: WT=20.45±3.55 and Mut=31.18±4.08 p=1.4x10-8, Theta: WT=18.53±1.47 and
Mut=20.00±2.84 p=0.1531, Alpha: WT=9.08±0.84 and Mut=10.86±1.73 p=0.0049, Beta:
WT=15.74±1.04 and Mut=15.37±1.77 p=0.5723, Gamma: WT=36.21±2.93 and Mut=22.58±3.39
p=2.9x10-15; Sleep; Delta: WT=19.85±2.83 and Mut=34.15±2.61 p=3.5x10-20, Theta:
WT=20.34±1.56 and Mut=18.24±1.91 p=0.0087, Alpha: WT=11.12±0.92 and Mut=9.49±0.92
p=0.00017, Beta: WT=16.97±0.88 and Mut=13.33±1.13 p=7.1x10-12, Gamma: WT=31.73±3.37
and Mut=24.78±4.00 p=0.000070; WT n=6 and Mut n=4). Error bars are S.E.
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Figure 3: Arx-/Y Emx1Cre mice have normal motor strength and coordination. A) The grip
strength test was used as measure of motor strength in the wildtype and mutant mice. Grip
strength for both fore and hind limbs was similar for the mutant and wildtype mice (Forelimb:
WT= 0.042±0.0033, n=13 and Mut=0.052±0.0053, n=12; p=0.1030; Hindlimb: WT=
0.079±0.0055, n=13 and Mut=0.082±0.0044, n=12; p=0.3447). B) The rotarod test was used as
measure of motor coordination. The mutant mice performed just as well in the rotarod test and
learned to stay on the rotarod just as quickly as their wildtype littermates (WT n=13 and Mut
n=12; p=0.0801). C) Home cage activity was similar for mutant mice and their wild type
littermates (WT=13.75±1.73, n=8 and Mut=12.59±1.84, n=8; p=0.5191). Error bars are S.E.

97

Figure 4: Arx-/Y Emx1-Cre mice have normal spatial learning and memory but impaired
fear-based memory. A) Mutant mice and wild type littermates were trained in the Morris water
maze for 5 days and the mutants learned how to reach the platform just as quickly as their wild
type littermates (WT n=20 and Mut n=21; p=0.0669). B) On day 6 with the platform removed
the mutant mice spent just as much time as their wild type littermates in the correct quadrant
showing that they remembered where the platform was located (time in platform quadrant in
seconds: WT=22.8±1.47 and Mut=25.6±1.97; p=0.271; time in opposite quadrant in seconds:
WT=9.61±1.07, n=20 and Mut=7.7±1.28, n=21; p=0.256). C) The reversal learning of the mice
was then tested by retraining them for another 5 days with the platform on the opposite quadrant
of the tank. The mutant mice relearned the task just as well as their wild type littermates (WT
n=20 and Mut n=21; p=0.1545). D) On day 12 the platform was again removed and the time the
mice spent in each quadrant was recorded. The mutant mice spent just as much time in the new
platform quadrant as their wild type littermates (time in platform quadrant in seconds:
WT=19.5±0.87 and Mut=19.9±1.33; p=0.762; time in opposite quadrant in seconds: WT=
11.7±0.85, n=20 and Mut=11.7±1.02, n=21; p=0.997). E) Contextual fear conditioning was used
98

to evaluate fear learning in wild type and mutant mice. During a 3 min training period the mice
were given a foot shock and the amount of time spent freezing was recorded. Twenty-four hours
later the mice were re-exposed to the context where they were given the foot shock and the
amount of time they spent freezing over a 5 min period was recorded. Mutant mice spent
significantly less time freezing as compared to their wild type littermates both in the training
period and during testing so therefore they did learn this task (percentage of time spent freezing
training: WT=10.5±1.06, n=17 and Mut=5.57±0.82, n=14; p=0.00099; percentage of time spent
freezing testing: WT=52.1±3.65, n=17 and Mut=34.4±4.99, n=14; p=0.0086). Error bars are S.E.
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Figure 5: Arx-/Y Emx1Cre mice are more active than their wild type littermates, but they do
learn the contextual fear conditioning task. A) The mutant mice traveled a larger distance
during the testing session of the fear conditioning task than their wild type littermates did
(WT=2.43±0.42, n=17 and Mut=4.00±0.49, n=14; p=0.0217) indicating they are more active
during the test. B) Therefore even though the mutant mice froze significantly less than their wild
type littermates they did so during both parts of the task so the ratio of freezing during training to
freezing during testing is not different between the two genotypes (WT=5.36±0.43, n=17 and
Mut=6.80±1.31, n=14; p=0.3097). Error bars are S.E.
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Figure 6: Arx-/Y Emx1-Cre mice are less anxious and more active than wild type mice. A) In
the Open Field test the ratio of time spent in the center to time spent in the outside area of the box
was used as a measure of anxiety. The mutant mice spent more time in the center of the box than
their wild type littermates indicating they are less anxious (WT= 0.170±0.019, n=20 and
Mut=0.229±0.020, n=21; p=0.0405). B) The linear distance traveled by the mice during their
fifteen minute testing period was calculated as a measure of their activity level. The mutant mice
traveled further than their wild type littermates during the open field test indicating that they are
hyperactive (WT= 65.9±3.02, n=20 and Mut=77.6±3.79, n=21; p=0.0201). C) For the Light/Dark
Box assay the ratio of time spent in the light side of the box to time spent in the dark side of the
box was used as a measure of anxiety. The mutant mice spent more time in the light side of the
box than their wild type littermates indicating that they are less anxious (WT= 0.891±0.118, n=20
and Mut=1.61±0.202, n=21; p=0.00204). D) The linear distance traveled by the mice during their
ten minute testing period was calculated as a measure of their activity level. The mutant mice
traveled further than their wild type littermates during the light/dark box test again indicating that
they are hyperactive (WT= 12.2±0.867, n=20 and Mut=20.2±1.13, n=21; p=0.000007). E) The
number of marbles buried in the Marble Burying assay was used as a measure of anxiety with
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increased burying meaning increased anxiety (WT= 6.13±1.25, n=8 and Mut=0±0, n=8;
p=0.00759). F) The amount of distance traveled by the mice during the thirty minute testing
period was used as a measure of activity level (WT= 85.34±2.10, n=8 and Mut=93.42±5.94, n=8;
p=0.2322). Error bars are S.E.
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Figure 7: Arx-/Y Emx1Cre mice are more active and have more crossings in the open field and
light/dark box tests. A) The mutant mice crossed from the center to the periphery in the open
field test more often than the wild type mice did (WT=117±6, n=20 and Mut=158±8, n=21;
p=0.0000863) indicating they are more active during the test. B) Similarly, the mutant mice
crossed from the light side to the dark side of the box in the light/dark box test more than the wild
type mice did (WT= 28±1, n=17 and Mut=40±4, n=14; p=0.00143). Error bars are S.E.
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Figure 8: Arx-/Y Emx1-Cre mice have social deficits. A) The social abilities of mutant and wild
type mice were assessed using the social choice test, the time spent in the novel mouse section
(social), the center of the box, and the novel object section (nonsocial) was compared using a
Two-way ANOVA. The mutant mice spent significantly less time in the social section of the box
than their wild type littermates did (Time spent in social section: WT= 142.07±8.54, n=15 and
Mut=111.37±4.28, n=18; p<0.001). B) The mutant mice spent significantly less time sniffing the
novel mouse tube than their wild type littermates did as compared to the object tube (Sniffing:
WT= 4.53±0.80, n=15 and Mut=2.15±0.18, n=18; p=0.01379). The mutant mice also entered the
social section of the box few times as compared to the non-social section than their wild type
littermates did (Entries: WT= 2.97±0.50, n=15 and Mut=1.44±0.14, n=18; p=0.00952). C) To
assess the olfactory ability of the mice the buried food test was used. If the mice have normal
olfactory abilities they should be able to find the Froot Loop buried in the bedding. Both the
mutant mice and their wild type littermates were equally capable of finding the Froot Loop.
(WT=143.38±34.86 and Mut=242.13±79.60, n=8 for each; p=0.2834). Error bars are S.E.
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Figure 9: Arx-/Y Emx1-Cre mice have hypoplastic corpus callosums and anterior
commissures. MRIs were made of three brains from mutant mice and three brains from their
wild type littermates. A) A midsagittal section from an MRI of a wild type brain. The white
arrows mark the rostral and caudal ends of a normal corpus callosum. C) A midsagittal section
from an MRI of a mutant brain. The white arrows again mark the ends of the corpus callosum
showing that the corpus callosum is both shorter and thinner in the mutant mice. B) A rostral
coronal section from an MRI of a wild type brain. The white arrow marks the middle of the
anterior commissure. D) A rostral coronal section from an MRI of a mutant brain. The white
arrow marks the middle of the anterior commissure showing that in the mutant it is much thinner.
E) Table of volumes (mm3) of brain regions of wild type and mutant mice from T2W MRI data
and comparisons between the wild type and mutant volumes for each region.
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Figure 10: Arx-/Y Emx1-Cre mice have a loss of neurons in the basolateral amygdala. A and
B) Coronal brain sections of adult mutant mice and their wild type littermates were stained with
Nissl, which labels all neurons. A’ and B’) Enlarged sections showing the basolateral amygdala
region (dotted white outline) which was counted. C) Quantification of number of neurons
counted in the basolateral amygdala of the Arx-/Y Emx1-Cre mice and their wild type littermates
showing that the mutant mice have fewer neurons in the basolateral amygdala as compared to
wild type littermates (WT=1118±124 and Mut=891±152, n=3 for each; p=0.01952). Error bars
are S.E.
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CHAPTER 4: Discussion

The work presented herein, expands the data on the role of Arx into its function in
dorsal progenitors. Mutations in ARX produce a spectrum of intellectual disability and
epilepsy phenotypes in human patients (Shoubridge C et al. 2010). Arx is expressed in
progenitor cells that produced both the excitatory and inhibitory neurons of the cerebral
cortex during development (Colombo E et al. 2004). However, Arx studies have focused
primarily on its role in interneurons during cortex development, as this was predicted to
be the cause of the severe epilepsy found in patients with ARX mutations. The original
report of Arx dysfunction in the mouse, however, found deficits in the proliferation and
thickness of the cerebral cortex as well as in interneuron migration (Kitamura K et al.
2002). The decreased proliferation in the pallial (the dorsal part of the developing
telencephalon) progenitor zone along with the expression of Arx in this region clearly
pointed to a role for Arx in cortical progenitor cell development (Kitamura K et al. 2002;
Colombo E et al. 2004).
To address the function of Arx in pallial progenitor cells, in utero electroporation
was performed with an shRNA construct, to decrease Arx expression, and an
overexpression construct, to observe changes with increased Arx function (Friocourt G et
al. 2008). Knockdown of Arx in the cortical progenitors was found to cause premature
cell cycle exit while Arx overexpression in the same population resulted in a lengthening
of the cell cycle (Friocourt G et al. 2008). However, the methodology used in these
experiments limits a full interpretation of the role of Arx in cortical progenitor cells, but
confirmed that Arx has a role in normal cortical progenitor cell proliferation and
107

differentiation. Thus, we sought to more thoroughly investigate the role of Arx in the
regulation of proliferation and differentiation of pallial progenitor cells during cortex
development. Employing conditional genetic methodologies we eliminated Arx from the
cortical proliferative zones by crossing the Emx1Cre driver mouse with the floxed Arx
mouse (Fulp CT et al. 2008). The result of this cross was to effectively abrogate Arx
specifically from the dorsal telencephalon cortical progenitor cells starting at embryonic
day 9.5 (E9.5). This removed Arx from those cells that will give rise to all cortical
excitatory neurons and glia, at the time of their birth and persisting through development.
Arx controls cortical progenitor cell number through repression of Cdkn1c
The Arx-/Y Emx1Cre mice were found to have smaller, thinner and somewhat
disorganized cortices along with agenesis of the corpus callosum, mimicking the
morphological abnormalities seen in Arx-/Y mice. The Arx-/Y mouse recapitulated some of
the structural abnormalities found in X-linked lissencephaly with ambiguous genitalia
patients (XLAG) with severe ARX mutations. This indicates that these abnormalities are
due to a loss of Arx in cortical progenitor cells rather than other cell types in the cortex.
These Arx-/Y Emx1Cre mice have fewer radial glia progenitor cells (RGCs) and
intermediate progenitor cells (IPCs) in their cortices during development (Chapter 2: Fig.
3). With decreased proliferation of the IPCs and increased cell cycle exit of the RGCs,
but normal cell cycle length for both types of progenitors (Chapter 2: Figs. 3, 5, and 7).
To uncover the transcriptional pathways mediating this loss of proliferation and
premature cell cycle exit we compared transcript profiles between Arx KO cortices and
wild type cortices. Eighty-three genes were found to be differentially expressed in the
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Arx KO cortices as compared to controls (Chapter 2: Fig. 11). One of these genes was
Cdkn1c, which was overexpressed in Arx KO cortices when compared to controls and at
e14.5 is overexpressed specifically in the VZ (ventricular zone) and SVZ (subventricular
zone). Cdkn1c is a cell cycle dependent kinase inhibitor that regulates cell cycle
progression. Expression of the protein results in cell cycle exit (Sherr CJ and JM Roberts
1999). Cdkn1c was determined to be a direct transcriptional target of Arx and therefore
the effector protein by which Arx regulates proliferation and cell cycle exit in cortical
progenitor cells. In agreement with this conclusion overexpression of Cdnk1c in the
cortex causes progenitor cells to exit the cell cycle and differentiate (Tury A et al. 2011).
Furthermore, mice with a loss of Cdnk1c have an increase of proliferation of RGCs and
IPCs with a greater effect on IPCs (Mairet-Coello G et al. 2012). Together this data
provides the most direct evidence for Arx regulating cell cycle exit through repression of
Cdnk1c in cortical progenitor cells.
The microarray expression profiles of Arx knockouts from different cortical and
subcortical regions provides clear evidence that Arx regulates different genes in different
cell types during different stages of development (Fulp CT et al. 2008; Colasante G et al.
2009)(Chapter 2: Fig. 11). For example Cdkn1c did not appear as a target on either of the
two microarrays of the ventral telencephalon, but it does in the dorsal telencephalon (Fulp
CT et al. 2008; Colasante G et al. 2009)(Chapter 2: Fig. 11). In fact, comparing the two
microarrays done by the same group but in different regions revealed only 5 target genes
found in both the dorsal and ventral telencephalon (Colasante G et al. 2009)(Chapter 2:
Fig. 11). This is not completely surprising given that Arx is expressed at different
developmental stages of the cell types formed from the ventral telencephalon verses the
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dorsal telencephalon. In the dorsal telecephalon, Arx is expressed in actively dividing
progenitor cells correlating with a regulatory role in the cell cycle. In the ventral
telencephalon Arx is expressed in the interneurons as they are born, during migration, and
into maturation, so it makes sense that in addition to another cohort of transcription
factors it would also regulate signaling receptors and cytoskeletal regulatory proteins.
From this data, our lab hypothesized that Arx is regulating different groups of genes in
different cell types explaining how varying mutations and/or a loss of the protein can
have differential effects in diverse brain regions. Supporting this hypothesis is work from
the Golden lab that found Arx with a polyalanine expansion mutation was sufficient for
normal excitatory neuron development but not interneuron development (Nasrallah MP et
al. 2012). The differential effect was apparently due to the Arx polyalanine tract
expansion mutation loosing the ability to repress a subset of its target genes, but not
others. This finding was reported to be due to a failure of Arx to bind to one of its
cofactors (Tle1) (Nasrallah MP et al. 2012). Another member of the Golden lab also
found that Arx has different binding preferences for different DNA sequences when it is
bound to different proteins, indicating it may bind with different cofactors in different
cell types (Cho G et al. 2012).
To further understand the network of genes regulated by Arx, Quille and
colleagues performed chromatin immunoprecipitation assays on promoter arrays from
both whole brain tissue and a neuroblastoma (N2a) cell line and compared the resulting
targets (Quille ML et al. 2011). Interestingly, this experiment did not pull down Cdkn1c,
but did pull down Cdkn1a, another cyclin dependent kinase inhibitor in the same family
of proteins with similar functions (Quille ML et al. 2011). Because the whole brain was
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used in this assay its impossible to know in what cell type Arx binds to Cdkn1a. It
remains possible that Arx binds to the promoter of Cdkn1a in the cortical progenitor cells
and regulates their cell cycle exit through expression of that gene or Arx could be
regulating Cdkn1a in a different cell type. Given our RT-PCR analysis in the dorsal
telencephalon showing there was no increase in the expression of Cdkn1a in the Arx
knockout as compared to controls, it seems most likely Arx is regulating Cdkn1a in a
different cell type (Chapter 2: Fig. 11).
Loss of Arx in the progenitor cells changes the structure of the cortex
The radial glia (RGCs) and intermediate progenitor cells (IPCs) give rise to all of
the excitatory neurons that will form the adult cortex. Therefore, by regulating cell cycle
exit in these two cortical progenitor populations Arx regulates both the number and types
of excitatory neurons produced in the cortex during development. There is currently
some debate in the field regarding whether IPCs can produce all of the excitatory neuron
subtypes in the cortex or whether they can only produce superficial layer neurons (for
review see (Kriegstein A et al. 2006; Pontious A et al. 2008)). Our finding of a loss of
superficial neurons in the adult cortex in the Arx-/Y Emx1Cre mice with a relative
preservation of deeper neurons is consistent with the hypothesis that intermediate
progenitor cells (IPCs) produce only upper layer neurons (Kriegstein A et al. 2006;
Pontious A et al. 2008)(Chapter 2: Fig. 10).
In turn this loss of upper layer neurons in the cortex seems to result in a loss of
connectivity in the brain as evidenced by the decrease in major white matter tracts, the
corpus callosum and the anterior commissure, that connect distant cortical regions
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(Chapter 2: Fig.1; Chapter 3: Fig. 9). In order to prove that the change is these white
matter tracts was a direct result of the loss of these upper layer neurons in the cortex more
experiments will need to be performed. For example a retrograde or anterograde label
(DiI or Neurobiotin) injected into the upper cortical layers in the Arx-/Y Emx1Cre mice and
wild type littermate controls could map projections of layer 2/3 axons to see if fewer are
found in the corpus callosum or the anterior commissure in the mutant mice. I performed
a series of these proposed experiments, but was unable to specifically label only layer 2/3
neurons, likely due to a technical issues with the injection methods employed.
Alternative methods include: a replication deficient lentivirus expressing GFP injected
into superficial cells in an adult brain and targets traced; permanently labeling layer 2-3
neurons by crossing the Arx-/Y Emx1Cre line with a Satb2 or Cux1 reporter mouse; or
using in utero electroporation of a Tau-GFP construct at e15.5 to label the projections of
the superficial layer neurons specifically. This embryonic method of labeling could be
useful for looking at these cells at different points of development to determine if perhaps
these cells do project early in development but are unable to maintain those projections.
Defects in the corpus callosum, either agenesis or hypoplasia, can be the result of
a primary failure of axons to cross the midline, or due to a primary loss or depletion in
the number of neurons producing the axons destined to cross the midline. Based on my
data I hypothesize that the corpus callosum is thinner due to decreased generation of
callosal projecting neurons in the superficial layers of the cortex. Therefore, no change
would be found in the remaining neuronal projections over the course of development
because the cells that are formed most likely project and are maintained normally. This is
how a transcription factor that is expressed only at one time point early in the
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development of these cortical cells can have a profound effect on the ultimate structure
and function of the cortex.
Arx-/Y Emx1Cre mice have slow background EEG
Our studies also provide some insight into the role of Arx in excitatory neurons
and how this influences electrical activity in the brain. Since Arx was only lost in the
excitatory neurons of the neocortex in Arx-/Y Emx1Cre mice it was not surprising that the
total number of interneurons and relative number of the two main subtypes of
interneurons was preserved in these mutants (Chapter 3: Fig. 1). Most interestingly,
unlike all other Arx mutant mouse models, the Arx-/Y Emx1Cre mice do not appear to have
seizures, further supporting the interneuron origin underlying epileptogenesis in these
mice. Even without seizures, the Arx-/Y Emx1Cre mice have an abnormal EEG pattern
with an increase in slower frequencies and a decrease of faster frequencies (Chapter 3:
Fig. 1). This slow EGG pattern is indicative of brain dysfunction and is seen in many
developmental disorders, particularly epileptic encephalopthies, such as Lennox-Gastaut
syndrome, Dravet’s syndrome, and West syndrome (Kandel ER et al. 2000; Zupanc ML
2009). West syndrome is caused by various mutations in ARX including polyalanine tract
expansions and duplications, missense mutations, and deletions (Turner G et al. 2002;
Hirose S and A Mitsudome 2003; Kato M et al. 2003; Kato M et al. 2004; Wohlrab G et
al. 2005; Demos MK et al. 2009; Cossee M et al. 2011). In addition, this increase in
slower frequencies and decrease of faster frequencies is also consistent with the EEGs of
children and adults with Attention Deficit Hyperactivity Disorder (ADHD) (Barry RJ et
al. 2010; van Dongen-Boomsma M et al. 2010; Loo SK and S Makeig 2012; Woltering S
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et al. 2012; Clarke AR et al. 2013) and our mutant mice appear hyperactive. Therefore,
the Arx-/Y Emx1Cre mice have an abnormal EEG background consistent with particular
ARX mutations in humans and ADHD patients.
This increase of slower frequencies and a decrease of faster frequencies seen in
the Arx-/Y Emx1Cre mice is the opposite of the Arx-/Y Dlx5/6Cre mice, which have a
decrease of slower frequencies and an increase of faster frequencies. In the Arx-/Y
Dlx5/6Cre mice, Arx is lost only in the ganglionic eminence and its derivatives, the
cortical interneurons, which generally have inhibitory roles in cortical circuits. The result
is fewer interneurons in the cortex, which presumably results in the observed decreased
inhibition relative to excitation in the cortex. This imbalance of inhibition relative to
excitation is thought to be the cause of seizures in these mice and in ARX patients. In the
Arx-/Y Emx1Cre mice the opposite is true, loss of Arx causes a loss of layer 2/3 pyramidal
cells which are excitatory and the interneurons are spared so presumably there would be
an increase in the inhibition in these cortices relative to the excitation. These intriguing
results provide the first data that the removal of particular cell types from the cortex can
cause specific changes in murine cortical EEG patterns. This represents, to the best of
my knowledge, the first example where the relative loss of inhibition in the cortex
decreases slow EEG frequencies and increases fast frequencies while a relative loss of
excitation only in the cortex induces an EEG shift to slower frequencies and a decrease of
fast frequencies.
Described above is one possible theory to explain our observations regarding the
disparate EEGs of these two Arx conditional knockout mice. To further validate this
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theory we would have to first show that there actually is a relative loss of inhibition or
excitation in the cortices of these two conditional knockout mice. This could be done by
recording field potentials in cortical slices of each of these mice. If these EEGs did
correlate with relative inhibition of excitation in the cortex then the next step would be to
find or generate additional mutant mice which are missing either particular excitatory or
inhibitory cells, preferably distinct from those lost in the mice we generated and from
other genetic mutations and examine the EEG recordings and field potentials of these
mutant mice as well. If particular EEG changes could be found to correlate with loss of
particular cell types in the cortex then EEGs in people could be used to diagnose more
diseases and hopefully lead to more specific treatments.
Behavioral Phenotype of Arx-/Y Emx1Cre mice
Patients with ARX mutations exhibit a spectrum of phenotypes with some
mutations having major structural brain malformations and others having normal
appearing brains. However, all ARX patients have some type of seizure disorder and
some level of intellectual disability (Marsh ED and JA Golden 2012). The Arx-/Y Emx1Cre
mice do not have seizures and have a normal lifespan, unlike most other Arx mutant
mice, but they do have morphological changes of their brains (Chapter 2: Fig. 1; Chapter
3: Fig. 1). Their cortex is smaller and thinner with a specific loss of superficial excitatory
neurons and their amygdala is smaller with fewer neurons in the basolateral amygdala.
They also have defects of white matter tracts in the brain including the corpus callosum
and the anterior commissure. Given these various anomalies we next sought to determine
if these morphological changes correlated with possible behavior anomalies. Since most
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mutations of ARX in people result in some form of intellectual disability we first tested
the learning and memory of the Arx-/Y Emx1Cre mice. To our surprise, the mice had
normal learning in all modalities tested. Spatial learning and memory, fear based
learning, and reversal learning were all normal (Chapter 3: Fig. 4). This is most
consistent with the fact that these mice do not have hippocampal defects. In rodents the
hippocampus drives much of the learning phenotype and it is normal in these animals.
The Arx-/Y Emx1Cre mice were also put through several anxiety tests and they were
found to be less anxious, more exploratory, and more active than their wild type
littermates (Chapter 3: Fig. 6). This anxiolytic and hyperactive phenotype could be the
result of the loss of neurons in the cortex or the amygdala or the loss of connections
within the limbic system. These mice also have a social deficit, an autistic feature, which
could also be related to this loss of neurons in the cortex and amygdala or a loss of
cortical connections (Chapter 3: Fig. 8).
Three other Arx mutant mice (Arx(GCG)7/Y, ArxPL/Y, Arx(GCG)10+7) have been
behaviorally phenotyped by two other labs and they have some similarities and
differences to the Arx-/Y Emx1Cre mice. The other three Arx mutant mice all have
impaired spatial learning and fear-based learning (Kitamura K et al. 2009; Price MG et al.
2009). The Arx(GCG)7/Y and ArxPL/Y mice are more anxious than their wild type littermates,
while the Arx(GCG)10+7 mice are less anxious, more active, and have social deficits similar
to the Arx-/Y;Emx1Cre mice (Kitamura K et al. 2009; Price MG et al. 2009). The
Arx(GCG)7/Y mice and the Arx(GCG)10+7 mice have severe seizures and die at a young age
(Kitamura K et al. 2009; Price MG et al. 2009). Only a few ArxPL/Y mice have seizures,
116

which are much less severe than the Arx(GCG)7/Y and Arx(GCG)10+7 mice and they have a
normal lifespan (Kitamura K et al. 2009). None of these Arx mutants have exactly the
same behavioral phenotype as the Arx-/Y Emx1Cre mice, but this is to be expected since the
Arx-/Y Emx1Cre mouse is a conditional knockout that only affects part of the brain. While
the other mutations may only affect part of the function of Arx, but are present in the
whole brain.
The morphological phenotype of these mutant mice also differs. The Arx(GCG)7/Y,
ArxPL/Y, and Arx(GCG)10+7 mice do not have the thinner cortex with an abnormal layer
structure and agenesis of the corpus callosum that is seen in the Arx knockout mouse and
the Arx-/Y Emx1Cre mouse, which could indicate that cortical progenitor cell proliferation
is not affected by these particular mutations to Arx (Kitamura K et al. 2009; Price MG et
al. 2009). However, the Arx(GCG)7/Y, ArxPL/Y, and Arx(GCG)10+7 mice have a loss of
interneurons in the cortex, hippocampus, and striatum while the Arx-/Y Emx1Cre mice have
normal numbers of interneurons. Interestingly, Arx-/Y Dlx5/6Cre mice, where Arx is only
removed from the GE derived cortical interneurons, also do not have a thinner cortex
with abnormal layering and agenesis of the corpus callosum. This also shows that this
morphological phenotype is caused by changes to the cortical progenitor cells and not the
interneurons (Marsh E et al. 2009).
The Arx(GCG)7/Y, ArxPL/Y, and Arx(GCG)10+7 mice all have some degree of epilepsy,
learning deficits, and a loss of interneurons although given their seizure frequency this
can be difficult to assess, whereas the Arx

-/Y

Emx1Cre mice have none of these

characteristics (Kitamura K et al. 2009; Price MG et al. 2009). Therefore, we can
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hypothesize that loss of interneurons is necessary for the development of epilepsy and
learning deficits both in these mice and presumably in human ARX patients. The Arx-/Y
Emx1Cre mice provide negative evidence that the epilepsy in ARX patients is caused by
problems with interneuron development and not the brain malformations seen in these
patients. These mice also provide evidence that the behavioral and cognitive deficits seen
in ARX patients might not be caused by the epilepsy. If this is true then the current
clinical dogma that controlling the epilepsy of these patients early on will improve their
cognitive and behavioral outcomes is incorrect and these patients may have the same
behavioral and cognitive deficits regardless of how well their epilepsy is controlled.
The morphological and behavioral phenotype of the Arx-/Y Emx1Cre mice makes
them a reasonable model to investigate the pathobiology underlying patients with mild
ARX mutations such as those with nonsyndromic X-linked intellectual disability, Proud
syndrome, Partington syndrome, and females with ARX mutations (Suri M 2005;
Shoubridge C et al. 2010). These mice could be used in future studies to understand how
the brains of these patients are altered and how these changes led to their particular
behavioral phenotypes. Once their phenotype is better understood they could also be
used to evaluate treatment options for these patients.
Connecting anxiety and autistic behaviors to changes in development
The other behaviors (low anxiety, hyperactivity, and social deficits) seen in
various Arx mutant mice (Arx-/Y Emx1Cre, Arx(GCG)7/Y, ArxPL/Y, and Arx(GCG)10+7 ) are more
difficult to attribute to a particular function of Arx or to particular groups of neurons in
the cortex. One reason for this is that these behaviors are controlled by the limbic
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system, which involves the entorhinal and pyriform cortex, amygdala, hippocampus, and
the connections between them. It has been reported that Arx is expressed in cells in the
adult amygdala, but its function in the amygdala has not been investigated (Poirier K et
al. 2004). We have shown that in the Arx-/Y Emx1Cre mice there are fewer neurons in the
basolateral amygdala. It would be interesting to look at whether other Arx mutant mice
also have a loss of neurons in the basolateral amygdala or perhaps to examine other
amygdala nuclei. If there is found to be consistent loss of neurons in the basolateral
amygdala of the Arx mutant mice then this could be a potential explanation for the
changes in anxiety and social behaviors in these mice.
A possible future direction of this work would be to examine which particular
neurons are lost from the basolateral amygdala of the Arx-/Y Emx1Cre mice or from other
Arx mutant mice. I would hypothesize that excitatory neurons are lost in the Arx-/Y
Emx1Cre mice because interneurons are born in the ventral areas of the brain that do not
express Emx1 and these mice have normal numbers of interneurons in the cortex. To test
this we could stain amygdala sections from the Arx-/Y Emx1Cre mice for Tbr1 or Mef2c or
do in situ hybridizations for Foxp2 or Meis2, which should all mark excitatory neurons in
the amygdala and compare the numbers of those cells in the mutant mice to their wild
type littermates (Remedios R et al. 2007; Waclaw RR et al. 2010; Cocas LA et al. 2011).
We could also label GAD67, Parv, or SST as we did with the cortex to confirm that there
is no loss of GABAergic neurons subtypes in the amygdala of these mice. Performing
similar studies on the other Arx mutant mice to determine which, if any, of the neuronal
subtypes are lost could also be informative in understanding both the role of Arx in
development and the consequences of specific neuronal loss to behavior. If these
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experiments were done, I would hypothesize that the Arx(GCG)7/Y and ArxPL/Y mutant mice
would have a loss of interneurons and/or GABAergic projections neurons in the
amygdala and no loss of excitatory cells similar to what has been demonstrated in the
cortex. Perhaps the loss of different subtypes of neurons in the amygdala could explain
the differences in anxiety behaviors seen in the different Arx mutant mice.
Another future direction of this work could be to examine whether connections
between the cortex and amygdala are lost in the Arx-/Y Emx1Cre mice either because of a
loss of neurons in the cortex or a loss of neurons in the amygdala. As with the white
matter tract studies, a labeling study using DiI or Neurobiotin in the dorsolateral
prefrontal cortex or anterior cingulate cortex could determine if there are fewer
projections to or from the amygdala in the Arx-/Y Emx1Cre mice. Conversely injections
into the basolateral and lateral amygdala could be performed to trace the corticalamygdala projections. If the Arx-/Y Emx1Cre mice are missing connections between the
cortex and the amygdala then the other Arx mutant mice should also be examined to
determine if they are missing the same connections and if they are missing connections
between the cortex and the amygdala that could be another explanation for the anxiety,
hyperactivity, and social deficits and could bring us closer to understanding the human
behavioral phenotype.
Ideally, to learn if any behavioral deficit could be correlated with specific cellular
or regional dysfunction related to Arx loss, one could use a more specific Cre line to
remove Arx either from the cortex, cortical subregions, such as prefrontal or
somatosensory, the amygdala or particular subnuclei. If such specific Cre lines could be
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developed the anxiety, hyperactivity, and social deficit behaviors of the resulting mice
could be examined and correlated with the underlying structural changes in the cortex,
amygdala or connections between the two.
Arx has different functions in different parts of the brain
Previous research on Arx has focused on where and when it is expressed during
development and what happens to the brain when it is absent or mutated (Kitamura K et
al. 2002; Kitamura K et al. 2009; Price MG et al. 2009). There has also been research
into what genes Arx regulates and how different mutations change its DNA binding and
repressive activities (McKenzie O et al. 2007; Colasante G et al. 2009; Quille ML et al.
2011; Cho G et al. 2012; Nasrallah MP et al. 2012; Shoubridge C et al. 2012). These
studies provide one explanation for the spectrum of phenotypes seen in human patients, a
close though not perfect genotype-phenotype correlation. For example an Arx protein
with a polyalanine expansion can bind to three of its known target genes (Lmo1, Shox2,
and Ebf3) but it can only repress Shox2 and Lmo1 (McKenzie O et al. 2007; Nasrallah
MP et al. 2012). While an Arx protein with a mutation in its homeodomain cannot bind
to or repress any of these three target genes (Cho G et al. 2012; Shoubridge C et al.
2012). Therefore, the phenotype of the homeodomain mutations is worse because the
protein is completely non-functional whereas the polyalanine expansion Arx mutation is
partially functional.
However, another explanation for the spectrum of phenotypes could be that Arx
has different functions in different cell types and some of the functions can be
accomplished by some mutations of Arx, but not by others. This would occur if different
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cell types have different cofactors that Arx interacts with to regulate different groups of
genes and some mutations may abolish binding to some cofactors but not others. Our lab
recently found that Arx with a polyalanine expansion has reduced binding to its known
cofactor Tle1, which could explain why it can no longer bind to the promoter regions of
Shox2 and Ebf3 (Nasrallah MP et al. 2012). Therefore, a future direction for the field
would be to look for cofactors of Arx and try to determine if different cell types at
different points in development express particular cofactors and this correlates with the
expression of particular groups of genes associated with particular cellular functions.
Our data has already provided some evidence for this alternative explanation for
the spectrum of ARX phenotypes. We have shown that Arx functions to regulate cell
cycle exit of progenitor cells in the cortex by regulating a distinct cohort of genes,
particularly Cdkn1c, from those already shown to be regulated in interneurons.
Therefore, loss of Arx in the cortical progenitor cells results in changes in the structure
and function of the cortex that are different from the changes in function that result from
the loss of Arx in interneurons. When Arx is lost in the cortical progenitor cells the adult
animal has a thinner cortex and agenesis of the corpus callosum, but does not have
seizures. Whereas the removal of Arx from interneurons results in an animal with a
normal appearing cortex that has fewer interneurons and does have seizures, which it
often succumbs to before adulthood (Marsh E et al. 2009).
Prior to the results presented here, Arx was known to function in cortical
proliferation and differentiation, but the exact mechanism was not known. We have now
revealed that Arx is regulating the cell cycle exit of cortical progenitor cells in the cortex
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by repressing the cyclin dependent kinase inhibitor Cdkn1c. This results in premature
exit of progenitor cells from the cell cycle, which ultimately results in a thinner cortex
due to loss of neurons from the superficial layers. We have correlated this finding in
adult mutant mice with lower anxiety, hyperactivity, and social deficits, providing
evidence for the cell types and circuits that are involved in these behaviors in mice and
presumably in humans. Hence, these mice can serve as a model of mild human ARX
patients and could aid in the understanding of both the physiology of the disease and be
used to test possible treatments for these behavioral symptoms.
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